Inflammatory diseases of the central nervous system

G6_NEUINFL

encephalomyelitis: Inflammation of the brain and the spinal cord.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G00-G09 Cause of death: ICD-10 — G00-G09 2 out of 7 registries used, show all original rules.	2463
4. Check minimum number of events None	2463
5. Include endpoints G6_MENINGBACT G6_MENINGVIR G6_MENINGOTH G6_ADEM G6_ENCEPHBACT G6_ENCEPHOTH G6_CNSABSC G6_CNSPHLEB G6_NEUROINFSEQ	3528
6. Filter based on genotype QC (FinnGen only)	3415

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	G6_NEUINFL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_MENINGBACT\|G6_MENINGVIR\|G6_MENINGOTH\|G6_ADEM\|G6_ENCEPHBACT\|G6_ENCEPHOTH\|G6_CNSABSC\|G6_CNSPHLEB\|G6_NEUROINFSEQ
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G0
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G0
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Inflammatory diseases of the central nervous system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30865	14355	16249
Only index persons	25199	12176	13023
Unadjusted period prevalence (%)
Whole population	0.43	0.41	0.45
Only index persons	0.47	0.45	0.50
Median age at first event (years)
Whole population	36.98	38.34	35.46
Only index persons	33.30	35.46	31.28

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3415	1860	1555
Unadjusted period prevalence (%)	0.68	0.66	0.71
Median age at first event (years)	42.32	39.01	46.27

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3528: Matched controls
35275

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

+∞

307.7

510

A87.9

ICD-10 Finland

Viral meningitis, unspecified

40.5

307.7

235

A86

ICD-10 Finland

Unspecified viral encephalitis

57.4

307.7

185

G03.9

ICD-10 Finland

Meningitis, unspecified

1277.4

307.7

447

32099

ICD-8 Finland

Meningitis, With no organism specified as cause

+∞

307.7

370

TAB00

NOMESCO Finland

Lumbar puncture

10.5

307.7

625

710

G00.9

ICD-10 Finland

Bacterial meningitis, unspecified

2928.3

294.7

281

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.3

292.2

672

1489

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

8.0

227.6

322

435

32088

ICD-8 Finland

Meningitis, Alia definita

+∞

210.5

200

AA1AD

NOMESCO Finland

CT of head and brain

3.1

210.2

1321

5750

G06.1

ICD-10 Finland

Intraspinal abscess and granuloma

+∞

205.2

195

N03AX14

ATC

levetiracetam; systemic

7.6

184.0

271

382

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

5.1

169.9

381

811

G06.0

ICD-10 Finland

Intracranial abscess and granuloma

+∞

165.9

158

G40.9

ICD-10 Finland

Epilepsy, unspecified

5.9

137.5

259

469

5AB01, ,

NOMESCO Finland

59.7

135.9

G05.1*B00.4

ICD-10 Finland

Herpesviral meningoencephalitis

+∞

132.1

126

XA800

NOMESCO Finland

Neuropsychological investigation

4.8

130.1

308

683

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

125.6

771

3193

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

7.2

125.4

191

278

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

10.8

122.9

134

128

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.8

120.8

761

3188

32000

ICD-8 Finland

Meningitis, H. influenzae

+∞

118.4

113

G04.8

ICD-10 Finland

Other encephalitis, myelitis and encephalomyelitis

+∞

115.2

110

G01*A69.2

ICD-10 Finland

Meningitis (in) Lyme disease

+∞

113.1

108

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

7.7

113.1

162

220

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.2

110.1

484

1654

R51.80

ICD-10 Finland

Headache

2.6

109.9

762

3336

32309

ICD-8 Finland

Encephalitis, myelitis and encephalomyelitis, Unspecified

+∞

108.9

104

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

6.8

101.4

163

251

G00.1

ICD-10 Finland

Pneumococcal meningitis

+∞

98.4

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

31.0

97.8

N03AX18

ATC

lacosamide; systemic

12.3

96.2

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.7

95.5

155

241

G02.0*B00.3

ICD-10 Finland

Herpesviral meningitis

+∞

93.1

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

11.0

92.4

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

8.4

90.0

118

144

3229X

ICD-9 Finland

Meningitis of unspecified cause, Meningitis, unspecified

+∞

88.9

R50.9

ICD-10 Finland

Fever, unspecified

2.4

84.7

677

3133

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.3

78.7

315

1010

N03AF02

ATC

oxcarbazepine; oral

4.4

77.8

204

488

AAF00

NOMESCO Finland

Ventriculostomy

13.0

76.9

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.6

76.4

271

804

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

74.0

1648

11119

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

70.3

860

4703

G09

ICD-10 Finland

Sequelae of inflammatory diseases of central nervous system

+∞

70.0

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

69.5

466

1975

M46.4

ICD-10 Finland

Discitis, unspecified

14.8

68.2

N03AB02

ATC

phenytoin; systemic

8.3

67.6

109

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

24.5

64.8

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.7

64.3

377

1493

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

14.6

62.2

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

62.2

637

3237

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

5.3

61.4

127

249

N03AX16

ATC

[U] pregabalin

2.0

61.4

888

5125

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

10.8

59.3

ZXD05

NOMESCO Finland

Urgent procedure

1.9

58.9

1134

7172

G06.2

ICD-10 Finland

Extradural and subdural abscess, unspecified

+∞

57.4

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.0

57.4

103

177

N03AG01

ATC

valproic acid; systemic, rectal

2.9

56.1

286

1050

N03AX12

ATC

[U] gabapentin; oral

2.1

54.4

636

3385

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

4.7

52.4

123

269

G91.0

ICD-10 Finland

Communicating hydrocephalus

11.4

51.8

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

6.8

51.8

121

N71

ICPC

Meningitis/encephalitis

515.3

51.6

G05.1*J09

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis in influenza caused by certain identified influenza viruses

+∞

51.2

ZX120

NOMESCO Finland

Intravenous

2.4

50.2

383

1711

R4120

NOMESCO Finland

Occupational therapy

2.7

49.9

287

1121

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.0

49.4

144

372

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

48.9

586

3137

6BA02, ,

NOMESCO Finland

15.7

48.6

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.9

48.5

107

222

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

+∞

48.0

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

14.5

47.6

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

9.8

47.5

N05BA09

ATC

clobazam; oral

9.5

47.2

G05.1

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere

+∞

47.0

G35

ICD-10 Finland

Multiple sclerosis

5.0

46.2

101

208

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

45.5

855

5296

B00.4

ICD-10 Finland

Herpesviral encephalitis

453.4

45.3

183

Kela drug reimbursment

Lamotrigin and topiramate

7.2

45.3

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

7.6

44.6

R4150

NOMESCO Finland

Neuropsychological rehabilitation

7.1

44.1

H02AB06

ATC

prednisolone; systemic

1.6

43.9

1620

12023

TKC20

NOMESCO Finland

Catheterisation of bladder

2.6

43.9

267

1071

G01*A39.0

ICD-10 Finland

Meningococcal meningitis

+∞

43.8

G05.1*B01.1

ICD-10 Finland

Varicella encephalitis

+∞

43.8

G03.8

ICD-10 Finland

Meningitis due to other specified causes

+∞

42.8

N03AF01

ATC

carbamazepine; oral, rectal

2.8

41.8

216

797

G03.0

ICD-10 Finland

Nonpyogenic meningitis

+∞

41.7

XA400

NOMESCO Finland

EEG

9.2

40.4

J01FF01

ATC

clindamycin; systemic

1.7

40.1

949

6244

WX882

NOMESCO Finland

High dependency care

3.6

40.0

135

386

R41.0

ICD-10 Finland

Disorientation, unspecified

3.6

39.2

132

377

G91.1

ICD-10 Finland

Obstructive hydrocephalus

10.9

39.1

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

38.8

890

5800

N02AX02

ATC

tramadol; systemic, rectal

1.6

38.5

1440

10617

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

7.1

38.1

A41.9

ICD-10 Finland

Sepsis, unspecified

3.2

37.8

154

496

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

37.8

479

2600

F05.9

ICD-10 Finland

Delirium, unspecified

4.4

37.7

224

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

7.0

37.7

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

6.1

37.5

108

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.7

37.5

121

336

J04AB02

ATC

rifampicin; systemic

5.3

37.4

143

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

11.3

37.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

37.1

456

2448

G41.9

ICD-10 Finland

Status epilepticus, unspecified

9.9

36.5

G05.1*B02.0

ICD-10 Finland

Zoster encephalitis

+∞

36.5

32300

ICD-8 Finland

Encephalitis, myelitis and encephalomyelitis, Encephalitis postinfectiosa

+∞

36.5

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

5.9

36.5

111

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.7

36.3

115

315

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

36.3

346

1689

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

36.2

221

887

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

36.0

335

1620

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.9

35.8

174

621

WX892

NOMESCO Finland

Monitored bed care

2.3

35.6

287

1307

G00.8

ICD-10 Finland

Other bacterial meningitis

+∞

35.5

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

35.1

271

1212

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

5.3

35.1

133

WX730

NOMESCO Finland

Conventional respirator

4.7

34.5

177

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

34.3

1183

8495

R4110

NOMESCO Finland

Physiotherapy

1.6

34.3

927

6275

2AB04, ,

NOMESCO Finland

12.2

34.1

Z2445

NOMESCO Finland

Psychologist

2.8

34.1

178

660

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

34.1

374

1925

SPAT1255

SPAT

Intravenous administration of medicine

2.3

33.6

263

1183

AAM00

NOMESCO Finland

Puncture and evacuation of intracerebral abscess

+∞

33.4

G00.3

ICD-10 Finland

Staphylococcal meningitis

+∞

33.4

R42

ICD-10 Finland

Dizziness and giddiness

1.7

33.1

737

4735

H02AB07

ATC

prednisone; oral

1.9

32.7

474

2683

N99

ICPC

Neurological disease other

5.0

32.6

142

A28

ICPC

Limited function/disability NOS

1.8

32.4

521

3045

G04.0

ICD-10 Finland

Acute disseminated encephalitis

+∞

32.3

G00.2

ICD-10 Finland

Streptococcal meningitis

+∞

32.3

L04AX01

ATC

azathioprine; systemic

2.7

32.0

177

676

L04AA06

ATC

mycophenolic acid; systemic

3.8

32.0

258

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

7.8

31.9

J05AB11

ATC

valaciclovir; oral

1.8

31.5

493

2856

A02BC02

ATC

pantoprazole; systemic

1.5

31.3

2234

18673

G02.0*B02.1

ICD-10 Finland

Zoster meningitis

+∞

31.3

3238B

ICD-9 Finland

Encephalitis, myelitis and encephalomyelitis, Other causes of encephalitis[ENCEPHALITIS (MYELITIS,ENCEPHALOMYELITIS) VIROSA]

+∞

31.3

Z3231

NOMESCO Finland

Registered nurse

1.6

31.2

912

6268

R51

ICD-10 Finland

Headache

2.4

31.2

220

945

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

12.0

30.8

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.1

30.4

328

1674

ZXC95

NOMESCO Finland

Use of surgical navigator

4.8

30.4

143

L28

ICPC

Limited function/disability (L)

1.8

30.1

558

3399

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

5.3

29.8

115

WX872

NOMESCO Finland

Intensive care

2.5

29.8

191

785

H02AB09

ATC

hydrocortisone; systemic

3.3

29.5

115

361

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.9

29.3

139

489

G03.1

ICD-10 Finland

Chronic meningitis

+∞

29.2

J01MA12

ATC

levofloxacin; systemic

1.7

29.0

607

3820

N02AA05

ATC

oxycodone; systemic

1.7

28.9

548

3355

G40.10

ICD-10 Finland

Simple partial seizures

6.6

28.9

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

34.0

28.7

N28

ICPC

Limited function/disability (N)

4.0

28.4

206

J01DB01

ATC

cefalexin; oral

1.6

28.3

2815

25003

G02.0*B01.0

ICD-10 Finland

Varicella meningitis

+∞

28.2

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

28.0

998

7152

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

27.9

654

4238

B94.1

ICD-10 Finland

Sequelae of viral encephalitis

146.1

27.7

N03AE01

ATC

clonazepam; systemic

2.3

27.6

217

977

ZXD35

NOMESCO Finland

Usual procedure

2.9

27.5

134

479

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.6

27.4

167

670

N03AX09

ATC

lamotrigine; oral

2.4

27.2

197

855

G51.0

ICD-10 Finland

Bell palsy

3.1

27.2

114

374

Z3226

NOMESCO Finland

Physiotherapist

1.7

27.0

607

3887

JN4BD

NOMESCO Finland

Extensive body CT

1.9

26.9

340

1833

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

26.9

423

2448

N05CF01

ATC

zopiclone; oral

1.5

26.9

1028

7469

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

5.4

26.8

100

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

26.7

637

4142

N05BA01

ATC

diazepam; systemic, rectal

1.8

26.7

440

2583

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.5

26.2

145

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

26.0

367

2053

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

4.8

25.9

122

H47.1

ICD-10 Finland

Papilloedema, unspecified

6.7

25.9

A06AD11

ATC

lactulose; oral

1.8

25.8

454

2715

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

6.6

25.5

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

25.4

163

670

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.2

25.1

220

1036

G01*A32.1

ICD-10 Finland

Listerial meningitis

+∞

25.0

3209X

ICD-9 Finland

Bacterial meningitis, Meningitis due to unspecified bacterium

+∞

25.0

JN4AD

NOMESCO Finland

Body CT examination

1.9

24.6

316

1713

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.7

24.4

211

N06AA09

ATC

amitriptyline; systemic

1.9

24.4

313

1696

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

24.4

739

5082

M03BX01

ATC

baclofen; systemic

3.4

24.2

270

R4130

NOMESCO Finland

Speech therapy

3.0

24.0

106

359

J01MA02

ATC

ciprofloxacin; systemic

1.5

23.9

1224

9390

AAA10

NOMESCO Finland

Biopsy through craniotomy

125.9

23.6

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

23.6

1174

8950

R33

ICD-10 Finland

Retention of urine

2.1

23.5

245

1233

A69.2

ICD-10 Finland

Lyme disease

2.2

23.5

203

950

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.9

23.5

108

374

G40.89

ICD-10 Finland

Other epilepsy

7.3

23.3

N29

ICPC

Neurological sympt/complt other

3.4

23.2

247

C03CA01

ATC

furosemide; systemic

1.5

23.2

840

5998

N05AH04

ATC

quetiapine; oral

1.6

23.0

596

3945

G05.1*J10.8

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis in influenza caused by other identified influenza virus

+∞

22.9

G04.2

ICD-10 Finland

Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified

+∞

22.9

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

22.9

328

1840

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

22.9

243

1231

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

22.9

235

1176

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

26.0

22.6

H53.2

ICD-10 Finland

Diplopia

2.6

22.4

128

497

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

22.3

312

1737

N03AX11

ATC

topiramate; oral

2.9

22.2

102

353

G44.2

ICD-10 Finland

Tension-type headache

1.7

22.2

450

2794

R53

ICD-10 Finland

Malaise and fatigue

1.5

22.1

765

5404

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

4.4

22.0

127

G02.0

ICD-10 Finland

Meningitis in viral diseases classified elsewhere

+∞

21.9

XCK00

NOMESCO Finland

Perimetry

2.2

21.9

197

938

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.7

21.8

194

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

21.8

1711

14116

AAM30

NOMESCO Finland

Evacuation of epidural or subdural empyema

80.6

21.7

G82.2

ICD-10 Finland

Paraplegia, unspecified

7.7

21.7

N02BE01

ATC

paracetamol; systemic, rectal

1.6

21.5

2967

27139

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

31.3

21.5

G40

ICD-10 Finland

Epilepsy

4.8

21.3

109

Kela drug reimbursment

Multiple sclerosis

4.0

21.2

152

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

23.3

21.2

WX704

NOMESCO Finland

Intubation

1.9

21.2

267

1436

R11

ICD-10 Finland

Nausea and vomiting

1.9

21.2

291

1611

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.6

21.0

199

32010

ICD-8 Finland

Meningitis, Pneumococcus

+∞

20.8

32400

ICD-8 Finland

Late effects of intracranial abscess or pyogenic infection, Hydrocephalus acquisitus

+∞

20.8

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

19.5

20.8

ZXY02

NOMESCO Finland

Neuropsychologist

5.7

20.7

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

20.5

880

6485

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

20.3

945

7068

N18

ICPC

Paralysis/weakness

3.3

20.3

243

J01AA02

ATC

doxycycline; systemic

1.4

20.1

2521

22405

J05AB01

ATC

aciclovir; systemic

1.5

20.1

686

4821

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

20.0

272

1499

Z2446

NOMESCO Finland

Social worker

2.0

20.0

232

1213

Z2221

NOMESCO Finland

Medical doctor

1.5

19.9

859

6328

N06AX21

ATC

duloxetine; oral

1.7

19.9

383

2342

N05BA04

ATC

oxazepam; oral

1.5

19.9

807

5874

G02.0*A87.0

ICD-10 Finland

Enteroviral meningitis

+∞

19.8

G01

ICD-10 Finland

Meningitis in bacterial diseases classified elsewhere

+∞

19.8

AAM10

NOMESCO Finland

Excision of intracerebral abscess

+∞

19.8

N06AX11

ATC

mirtazapine; oral

1.4

19.4

1064

8196

N01

ICPC

Headache

1.7

19.3

368

2243

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

19.3

273

1524

ZXA00

NOMESCO Finland

Right side

1.5

19.2

785

5719

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.7

19.2

105

400

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

19.1

541

3642

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

19.1

352

2126

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.4

19.0

198

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.8

19.0

345

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

19.0

171

814

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

3.9

18.9

147

R47.0

ICD-10 Finland

Dysphasia and aphasia

4.5

18.9

100

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

18.8

462

3007

G03.2

ICD-10 Finland

Benign recurrent meningitis [Mollaret]

+∞

18.8

G00.0

ICD-10 Finland

Haemophilus meningitis

+∞

18.8

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

23.8

18.6

M05BA04

ATC

alendronic acid; oral

1.9

18.6

246

1345

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

18.3

156

726

H53.4

ICD-10 Finland

Visual field defects

3.1

18.2

239

H47.2

ICD-10 Finland

Optic atrophy

7.2

18.2

PA2AD

NOMESCO Finland

CT angiography of brain

4.7

18.0

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.6

18.0

32308

ICD-8 Finland

Encephalitis, myelitis and encephalomyelitis, Alia definita

+∞

17.7

G05.1*A85.0

ICD-10 Finland

Encephalitis, myelitis or encephalomyelitis (in) enteroviral

+∞

17.7

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

66.9

17.7

0499X

ICD-9 Finland

Other non-arthropod-borne viral diseases of central nervous system, Unspecified non-arthropod-borne viral diseases of central nervous system

20.1

17.7

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

5.2

17.7

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.9

17.6

221

1186

G37.3

ICD-10 Finland

Acute transverse myelitis in demyelinating disease of central nervous system

95.5

17.6

NAS20

NOMESCO Finland

Incision and debridement of infection of vertebra, unspecified

95.5

17.6

N05CD07

ATC

temazepam; oral

1.7

17.4

337

2063

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.0

17.4

120

A02BC01

ATC

omeprazole; systemic

1.4

17.3

806

6005

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.3

17.2

136

614

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

17.1

177

888

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

6.4

17.1

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.0

17.0

192

995

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

16.9

531

3653

WW400

NOMESCO Finland

Plasmaferesis

19.4

16.8

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

16.7

230

1272

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

16.7

205

1092

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.8

16.7

306

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

16.7

613

4354

A87.8

ICD-10 Finland

Other viral meningitis

63.6

16.7

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

16.7

328

2013

B00.3

ICD-10 Finland

Herpesviral meningitis

+∞

16.7

N73

ICPC

Neurological infection other

35.2

16.7

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

16.6

190

988

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

16.6

380

2426

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

5.5

16.6

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

16.6

1393

11440

P01BA02

ATC

hydroxychloroquine; oral

1.8

16.6

253

1446

B01AB05

ATC

enoxaparin; parenteral

1.4

16.5

915

7022

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.3

16.4

119

518

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

20.1

16.4

SPAT1254

SPAT

Administration of medicine

1.6

16.4

440

2921

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

16.3

188

981

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

16.3

402

2615

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

3.8

16.2

126

UKC02

NOMESCO Finland

Cystoscopy

1.6

16.2

444

2962

P01AB01

ATC

metronidazole; oral, rectal

1.4

16.1

1212

9773

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

11.7

16.0

AAK00

NOMESCO Finland

Cranioplasty

18.6

16.0

J01MA14

ATC

moxifloxacin; systemic

1.7

15.9

275

1629

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

15.9

177

912

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

5.4

15.9

S97

ICPC

Chronic ulcer skin

2.0

15.9

179

927

N02BF01

ATC

gabapentin; oral

1.8

15.7

257

1499

3201A

ICD-9 Finland

Bacterial meningitis, Pneumococcal meningitis

+∞

15.6

F07.1

ICD-10 Finland

Postencephalitic syndrome

+∞

15.6

3200A

ICD-9 Finland

Bacterial meningitis, Haemophilus meningitis

+∞

15.6

B34.9

ICD-10 Finland

Viral infection, unspecified

2.4

15.6

103

430

N02BF02

ATC

pregabalin; oral

1.9

15.6

188

997

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

15.6

2321

20698

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

15.5

1141

9155

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

22.1

15.5

J01DA01

ATC

[U] cefalexin

1.3

15.5

1974

17189

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

15.5

1315

10788

ZXA05

NOMESCO Finland

Left side

1.4

15.5

709

5251

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.3

15.4

114

501

S18

ICPC

Laceration/cut

1.3

15.3

1363

11252

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

15.3

196

1059

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

15.3

334

2107

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

3.6

15.3

141

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.2

15.2

129

601

A46

ICD-10 Finland

Erysipelas

1.6

15.0

417

2786

H02AB04

ATC

methylprednisolone; systemic

1.6

15.0

430

2894

AA1AA

NOMESCO Finland

Head X-ray examination

4.3

15.0

N06AX16

ATC

venlafaxine; oral

1.5

15.0

447

3036

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

14.9

562

4008

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

14.7

238

1383

WX002

NOMESCO Finland

Sedation and analgesia

1.5

14.7

557

3977

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.6

14.6

323

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.7

14.5

127

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.4

14.5

156

RS221, ,

NOMESCO Finland

3.2

14.4

182

04599

ICD-8 Finland

Aseptic mentingitis due to enterovirus, Aseptic meningitis, unspecified

17.0

14.3

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

14.3

398

2662

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

10.5

14.2

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.7

14.1

120

N30.0

ICD-10 Finland

Acute cystitis

1.5

14.1

458

3166

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

14.1

250

1493

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.0

14.1

151

769

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.2

14.0

111

503

R60.0

ICD-10 Finland

Localized oedema

1.6

13.9

341

2213

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.8

13.9

196

1094

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

23.9

13.8

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

3.7

13.7

118

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

13.6

290

1817

S06.0

ICD-10 Finland

Concussion

1.6

13.6

329

2127

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.0

13.6

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

14.7

13.6

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

14.7

13.6

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

13.5

277

1721

A39.0

ICD-10 Finland

Meningococcal meningitis

140.5

13.5

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

13.4

736

5610

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

4.2

13.4

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

13.4

211

1218

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

3.6

13.3

125

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.0

13.3

151

785

G41.0

ICD-10 Finland

Grand mal status epilepticus

13.8

13.2

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

13.2

1074

8707

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

13.1

104

472

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

13.0

1086

8831

G91.8

ICD-10 Finland

Other hydrocephalus

19.1

12.9

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.0

12.9

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

4.0

12.9

L04AA01

ATC

[U] ciclosporin

3.2

12.9

158

X58

ICD-10 Finland

Exposure to other specified factors

1.5

12.9

442

3089

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.5

12.8

308

A84.8

ICD-10 Finland

Other tick-borne viral encephalitis

50.2

12.8

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

12.8

627

4683

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

12.8

124

609

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

12.7

127

630

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.6

12.7

292

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.0

12.7

191

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

12.6

129

646

Z71.8

ICD-10 Finland

Other specified counselling

1.3

12.6

929

7411

SPAT1229

SPAT

Assessment of need for aid

1.7

12.5

209

1228

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

12.5

448

3158

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

12.4

395

2717

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

12.4

141

734

J01CA04

ATC

amoxicillin; systemic

1.3

12.3

2686

24805

M54.5

ICD-10 Finland

Low back pain

1.3

12.3

1088

8906

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

12.3

686

5236

G61.0

ICD-10 Finland

Guillain-Barré syndrome

5.4

12.3

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

12.2

181

1026

GBB00

NOMESCO Finland

Tracheostomy

3.4

12.2

123

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

12.2

175

983

J01EA01

ATC

trimethoprim; systemic

1.4

12.1

730

5638

R52.2

ICD-10 Finland

Other chronic pain

2.1

12.1

119

587

U07

ICPC

Urine symptom/complaint other

1.7

12.1

206

1216

SPAT1234

SPAT

Support of social functional capacity

1.9

12.1

147

783

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

12.0

143

756

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.7

12.0

236

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.6

12.0

259

E23.00

ICD-10 Finland

Panhypopituitarism

5.2

12.0

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

5.2

12.0

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.1

12.0

165

N03AX23

ATC

brivaracetam; systemic

9.3

12.0

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

3.4

11.9

120

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.7

11.9

237

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

3.8

11.9

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

11.9

355

2408

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

4.7

11.9

A02BC05

ATC

esomeprazole; systemic

1.3

11.9

1196

9956

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

11.8

183

1051

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

11.8

888

7093

R40.2

ICD-10 Finland

Coma, unspecified

3.9

11.8

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

11.8

321

2133

N06AB04

ATC

citalopram; systemic

1.4

11.8

609

4586

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

3.4

11.8

126

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.2

11.7

429

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.4

11.7

N88

ICPC

Epilepsy

4.5

11.6

N05CD08

ATC

midazolam; nasal, systemic

2.5

11.6

305

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.2

11.6

411

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.2

11.6

137

R03AC02

ATC

salbutamol; inhalant

1.3

11.6

1698

14815

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

11.6

298

1955

B02.0

ICD-10 Finland

Zoster encephalitis

22.9

11.6

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

11.5

676

5195

SPAT1216

SPAT

Assessment of functional ability

1.5

11.5

412

2901

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

11.5

182

1053

J01CF02

ATC

cloxacillin; systemic

2.5

11.5

277

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

120.4

11.4

A10AB05

ATC

insulin aspart; parenteral

1.7

11.4

225

1383

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

11.4

415

A02BC03

ATC

lansoprazole; oral

1.3

11.4

813

6442

G95.9

ICD-10 Finland

Disease of spinal cord, unspecified

11.8

11.3

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.0

11.3

118

596

K90

ICPC

Stroke/cerebrovascular accident

2.3

11.3

378

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

11.2

545

4057

UJF32

NOMESCO Finland

Coloscopy

1.4

11.2

715

5564

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

11.2

140

752

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

11.2

138

739

G83.4

ICD-10 Finland

Cauda equina syndrome

5.6

11.2

TJD20

NOMESCO Finland

Change of gastrostomy tube

5.6

11.2

SPAT1167

SPAT

Insertion of urinary catheter

2.3

11.1

380

101

Kela drug reimbursment

Anterior pituitary hypofunction

3.7

11.1

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.9

11.1

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

8.0

11.1

N05AX08

ATC

risperidone; systemic

1.6

11.0

236

1481

U04

ICPC

Incontinence urine

1.9

11.0

141

764

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

11.0

118

602

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.8

11.0

A03

ICPC

Fever

1.4

11.0

505

3723

A04AA01

ATC

ondansetron; systemic, rectal

1.7

10.9

220

1359

M48.0

ICD-10 Finland

Spinal stenosis

1.5

10.9

322

2177

XKC03

NOMESCO Finland

Water cystometry

2.2

10.9

396

A87.0

ICD-10 Finland

Enteroviral meningitis

43.4

10.9

W19

ICD-10 Finland

Unspecified fall

1.6

10.9

278

1821

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

10.9

416

2966

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

5.4

10.9

G63.0*A69.2

ICD-10 Finland

Polyneuropathy (in) Lyme disease

11.9

10.8

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

10.8

411

N06BA07

ATC

modafinil; oral

5.1

10.8

K08.3

ICD-10 Finland

Retained dental root

1.7

10.8

214

1318

AAF15

NOMESCO Finland

Ventriculoatrial shunt

10.6

10.8

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

8.8

10.7

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.9

10.7

135

728

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

10.7

122

636

A04

ICPC

Weakness/tiredness general

1.5

10.7

416

2974

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

10.7

177

1037

J96.0

ICD-10 Finland

Acute respiratory failure

3.2

10.7

134

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.7

10.7

ZXE00

NOMESCO Finland

One hour or less

1.3

10.6

1146

9589

127

Kela drug reimbursment

Transplant complication

2.7

10.6

211

B01AA03

ATC

warfarin; systemic

1.4

10.6

480

3530

N03AX22

ATC

perampanel; oral

11.2

10.5

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

10.5

165

953

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.9

10.5

162

G82.5

ICD-10 Finland

Tetraplegia, unspecified

14.2

10.5

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

10.5

196

1189

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

10.4

1243

10529

3240A

ICD-9 Finland

Intracranial and intraspinal abscess, Intracranial abscess

+∞

10.4

32200

ICD-8 Finland

Intracranial and intraspinal abscess, Intracerebralis

+∞

10.4

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

10.4

575

4372

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

10.4

230

1457

F05.8

ICD-10 Finland

Other delirium

4.2

10.3

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

4.3

10.3

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

3.2

10.3

127

XKD00

NOMESCO Finland

Uroflowmetry

1.5

10.3

394

2810

AAK40

NOMESCO Finland

Closure of cerebrospinal fluid fistula

18.8

10.2

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

18.8

10.2

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.5

10.2

268

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

10.2

119

625

ZXA10

NOMESCO Finland

Bilateral

1.4

10.2

499

3715

M46.2

ICD-10 Finland

Osteomyelitis of vertebra

23.4

10.2

WX402

NOMESCO Finland

General anaesthesia

1.4

10.2

618

4766

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

10.2

134

733

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.0

10.2

108

550

M54.1

ICD-10 Finland

Radiculopathy

1.9

10.1

119

627

N07BC02

ATC

methadone; systemic

5.3

10.1

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

10.1

248

1611

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

10.0

274

1822

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.0

10.0

R06.0

ICD-10 Finland

Dyspnoea

1.3

10.0

742

5896

K59.0

ICD-10 Finland

Constipation

1.8

10.0

151

862

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

10.0

WW200

NOMESCO Finland

Immunization

2.1

10.0

418

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

9.9

1192

10089

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.1

9.9

130

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

9.9

106

542

M01AE02

ATC

naproxen; oral, rectal

1.3

9.9

1745

15456

J01CF05

ATC

flucloxacillin; systemic

1.7

9.8

180

1085

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

12.2

9.8

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

4.9

9.8

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

8.7

9.8

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

9.8

173

1034

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

9.8

192

1180

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

3.8

9.8

R55

ICD-10 Finland

Syncope and collapse

1.5

9.7

286

1933

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

9.7

783

6294

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

9.7

133

738

J01FA10

ATC

azithromycin; systemic

1.3

9.7

1797

15991

79199

ICD-8 Finland

Headache

2.9

9.6

154

H46

ICD-10 Finland

Optic neuritis

3.3

9.6

107

R27.0

ICD-10 Finland

Ataxia, unspecified

5.0

9.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

9.6

136

763

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.6

9.6

205

J02AC01

ATC

fluconazole; systemic

1.3

9.6

1123

9472

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

9.5

331

2314

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

9.5

323

2248

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

9.5

139

787

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

3.0

9.4

139

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.5

9.4

242

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.3

9.4

108

J01FA06

ATC

roxithromycin; oral

1.3

9.4

1170

9930

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

9.4

249

1644

B02.1

ICD-10 Finland

Zoster meningitis

30.1

9.4

A89

ICD-10 Finland

Unspecified viral infection of central nervous system

30.1

9.4

ADB00

NOMESCO Finland

Implantation of vagus nerve stimulating device

17.6

9.4

B94.80

ICD-10 Finland

Late effects of bacterial meningitis

+∞

9.4

G05.1*J11.8

ICD-10 Finland

Encephalitis, myelitis or encephalomyelitis in suspected influenza

+∞

9.4

G08

ICD-10 Finland

Intracranial and intraspinal phlebitis and thrombophlebitis

+∞

9.4

G01*A17.0

ICD-10 Finland

Tuberculous meningitis

+∞

9.4

XX3XW, ,

NOMESCO Finland

4.2

9.4

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

9.4

180

1100

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

9.3

216

1383

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

9.3

264

1771

102

Kela drug reimbursment

Diabetes insipidus

8.7

9.3

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

9.5

9.3

B02.8

ICD-10 Finland

Zoster with other complications

4.1

9.2

A41.8

ICD-10 Finland

Other specified sepsis

2.5

9.2

215

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

9.2

102

528

ZY010

NOMESCO Finland

Hospital outpatient

1.7

9.1

156

923

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

9.1

145

841

N05AH03

ATC

olanzapine; systemic

1.6

9.1

188

1170

N07

ICPC

Convulsion/seizure

8.3

9.0

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.6

9.0

205

N07BA03

ATC

varenicline; oral

1.8

9.0

142

821

120

Kela drug reimbursment

Hypogammaglobulinaemia

9.0

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

7.0

9.0

M03BX02

ATC

tizanidine; oral

1.2

9.0

1920

17290

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

9.0

393

2870

A10AB04

ATC

insulin lispro; parenteral

2.0

9.0

491

C07AB07

ATC

bisoprolol; oral

1.2

8.9

1332

11527

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

3.8

8.9

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.0

8.9

471

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.0

8.9

437

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.4

8.9

261

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

3.1

8.9

112

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

8.9

312

R5110, ,

SPAT

1.7

8.9

168

1023

L01BA01

ATC

methotrexate; systemic

1.9

8.9

103

542

R03BA05

ATC

fluticasone; inhalant

1.4

8.8

513

3924

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

3.6

8.8

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

8.8

216

1402

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

8.8

198

1259

G93.4

ICD-10 Finland

Encephalopathy, unspecified

8.6

8.8

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

8.6

8.8

G41.2

ICD-10 Finland

Complex partial status epilepticus

10.7

8.8

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.0

8.8

129

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

8.7

482

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

8.7

248

1665

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

4.1

8.7

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

8.7

182

1137

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

8.7

195

1240

A32.7

ICD-10 Finland

Listerial sepsis

14.0

8.7

ABD40

NOMESCO Finland

Implantation of spinal injection device

50.1

8.7

Z43.5

ICD-10 Finland

Attention to cystostomy

4.3

8.6

AA5PD

NOMESCO Finland

CT examination of brain pefusion

3.2

8.6

104

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

8.6

151

901

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

3.7

8.6

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

8.6

359

2599

N06AB10

ATC

escitalopram; oral

1.3

8.6

593

4657

L01AX03

ATC

temozolomide; systemic

3.6

8.5

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

8.5

279

1928

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.0

8.5

431

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

10.0

8.5

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.1

8.5

110

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

8.5

303

2131

R35

ICD-10 Finland

Polyuria

1.6

8.5

178

1114

L29

ICPC

Musculoskeletal sympt/complt other

1.5

8.4

227

1506

A10AC01

ATC

insulin (human); parenteral

1.6

8.4

210

1369

AAE05

NOMESCO Finland

Nasoendoscopic closure of cerebrospinal fluid fistula

90.3

8.4

J01XX08

ATC

linezolid; systemic

3.6

8.4

R1260

NOMESCO Finland

Evaluation of communicative skills

2.4

8.4

225

J45.8

ICD-10 Finland

Mixed asthma

2.0

8.4

441

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

8.3

187

1189

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.4

8.3

B01.1

ICD-10 Finland

Varicella encephalitis

+∞

8.3

RS222, ,

NOMESCO Finland

2.8

8.3

144

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

8.3

787

6444

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

8.3

189

1206

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.7

8.3

135

789

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

10.8

8.3

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.8

8.3

139

R52.1

ICD-10 Finland

Chronic intractable pain

3.1

8.2

107

ABE50

NOMESCO Finland

Occipitocervical decompression

14.5

8.2

J01CA08

ATC

pivmecillinam; oral

1.2

8.2

1100

9390

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

8.1

352

2565

XLA10, ,

NOMESCO Finland

1.8

8.1

122

698

N03AX25

ATC

cenobamate; oral

33.4

8.1

ZZC00

NOMESCO Finland

Graft of fascia

11.7

8.1

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

11.7

8.1

B01AB04

ATC

dalteparin; parenteral

1.7

8.0

139

827

Z98.2

ICD-10 Finland

Presence of cerebrospinal fluid drainage device

22.1

8.0

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

3.6

8.0

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

8.0

343

2495

S01.0

ICD-10 Finland

Open wound of scalp

1.5

8.0

212

1402

A29

ICPC

General symptom/complaint other

1.4

8.0

327

2359

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.5

8.0

S06.3

ICD-10 Finland

Focal brain injury

2.8

8.0

142

L04AX03

ATC

methotrexate; systemic

1.5

7.9

269

1872

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

7.9

138

822

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.6

7.9

171

G44.8

ICD-10 Finland

Other specified headache syndromes

2.5

7.9

195

C01CA24

ATC

epinephrine; parenteral

1.6

7.9

186

1198

N02CA01

ATC

dihydroergotamine; nasal, systemic

6.1

7.8

5CM18, ,

NOMESCO Finland

6.1

7.8

NHQ40

NOMESCO Finland

Amputation of toe

2.6

7.8

172

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

7.8

144

872

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

7.8

122

706

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.5

7.7

197

NA7CM

NOMESCO Finland

Spine and spinal cord extensive MRI examination with 3 Tesla magnet

15.0

7.7

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

7.7

189

1229

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.8

7.7

128

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

7.7

179

1150

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

7.7

352

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

4.5

7.6

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.9

7.6

534

M79.6

ICD-10 Finland

Pain in limb

1.2

7.6

1199

10397

QBG00

NOMESCO Finland

Debridement of bedsore of trunk

25.1

7.6

AWW99

NOMESCO Finland

Other reoperation in surgery of the nervous system

25.1

7.6

GBB03

NOMESCO Finland

Percutaneous tracheostomy

25.1

7.6

G04BD08

ATC

solifenacin; oral

1.6

7.6

159

996

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.3

7.6

230

K91

ICPC

Cerebrovascular disease

2.6

7.5

158

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

7.5

133

797

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

7.5

1409

12433

SPAT1172

SPAT

Guidance concerning hydration

2.3

7.5

250

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

7.5

142

867

N02AC04

ATC

dextropropoxyphene; oral

1.9

7.5

488

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

7.4

244

1688

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.5

7.4

183

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

7.4

536

4231

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

7.4

244

1690

G95.0

ICD-10 Finland

Syringomyelia and syringobulbia

7.6

7.4

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

7.6

7.4

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.1

7.4

337

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

3.3

7.4

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.3

7.4

239

J01CF01

ATC

dicloxacillin; systemic

3.7

7.3

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

7.3

493

3853

J01DA09

ATC

[U] cefadroxil

1.3

7.3

752

6211

3202A

ICD-9 Finland

Bacterial meningitis, Streptococcal meningitis

+∞

7.3

32401

ICD-8 Finland

Late effects of intracranial abscess or pyogenic infection, Status postencephaliticus

+∞

7.3

G05.0*A17.8

ICD-10 Finland

Tuberculous meningoencephalitis

+∞

7.3

A32.1

ICD-10 Finland

Listerial meningitis and meningoencephalitis

+∞

7.3

G992, G061,

ICD-10 Finland

+∞

7.3

34510

ICD-8 Finland

Epilepsy, """"Grand mal""""

10.9

7.3

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

9.4

7.3

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.1

7.3

339

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

4.1

7.3

B00.9

ICD-10 Finland

Herpesviral infection, unspecified

3.5

7.3

R1250

NOMESCO Finland

Evaluation of functional capability

2.1

7.2

326

G43.3

ICD-10 Finland

Complicated migraine

2.3

7.2

222

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

7.2

320

2341

M31.1

ICD-10 Finland

Thrombotic microangiopathy

15.8

7.2

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.3

7.2

235

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

7.1

415

3172

23810

ICD-8 Finland

Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain

20.0

7.1

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

3.4

7.1

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

6.6

7.1

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

7.1

157

997

G72.8

ICD-10 Finland

Other specified myopathies

2.4

7.1

181

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

7.1

478

3736

K93

ICPC

Pulmonary embolism

3.0

7.1

101

OAB93, ,

SPAT

1.6

7.1

166

1069

R03BA02

ATC

budesonide; inhalant

1.3

7.1

485

3799

R06AE07

ATC

cetirizine; oral

1.2

7.1

1296

11389

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

1.8

7.1

106

607

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

8.8

7.0

SPAT1301

SPAT

No procedures

1.2

7.0

847

7120

NA7DM

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with 3 Tesla magnet

10.0

7.0

XX4AW, ,

NOMESCO Finland

10.0

7.0

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

10.0

7.0

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.4

7.0

194

N05CF02

ATC

zolpidem; oral

1.3

7.0

479

3751

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

3.2

7.0

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

7.0

146

915

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.0

6.9

366

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.8

6.9

107

618

TGC00

NOMESCO Finland

Bronchial lavation

2.0

6.9

332

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

6.9

103

589

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

7.5

6.9

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.3

6.9

221

A07AA02

ATC

nystatin; oral

1.6

6.9

147

926

D33.30

ICD-10 Finland

Acoustic neuroma

3.6

6.9

N05AA02

ATC

levomepromazine; systemic

1.7

6.8

109

635

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

2.9

6.8

103

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

2.5

6.8

154

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

2.6

6.8

137

G81.1

ICD-10 Finland

Spastic hemiplegia

10.9

6.8

R50.0

ICD-10 Finland

Fever with chills

9.3

6.8

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

9.3

6.8

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

4.3

6.7

A07EA06

ATC

budesonide; oral, local oral

1.8

6.7

549

H57.1

ICD-10 Finland

Ocular pain

1.7

6.7

106

617

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

2.8

6.7

110

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.4

6.7

174

A85.8

ICD-10 Finland

Other specified viral encephalitis

22.5

6.7

R4190

NOMESCO Finland

Nutritional therapy

1.8

6.7

103

595

A07AA09

ATC

vancomycin; oral

2.5

6.7

162

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

6.7

182

1213

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

6.7

1493

13353

E0000UV, ,

ATC

1.2

6.7

1190

10415

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.9

6.6

435

JN6AD

NOMESCO Finland

CT of torso and neck

2.4

6.6

181

N03AX15

ATC

zonisamide; oral

5.9

6.6

A40.0

ICD-10 Finland

Sepsis due to streptococcus, group A

5.9

6.6

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

5.5

6.6

G04BD09

ATC

trospium; oral

2.1

6.6

284

R10.0

ICD-10 Finland

Acute abdomen

1.8

6.6

465

SPAT1262

SPAT

Handing over of treatment supplies

1.3

6.6

446

3486

N06AB03

ATC

fluoxetine; oral

1.4

6.6

330

2465

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.1

6.6

278

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.6

6.5

127

781

J15.8

ICD-10 Finland

Other bacterial pneumonia

3.3

6.5

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

3.3

6.5

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

8.7

6.5

M32

ICD-10 Finland

Systemic lupus erythematosus

10.0

6.5

PA6AD

NOMESCO Finland

CT of neck arteries

1.9

6.5

396

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.8

6.5

112

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

3.1

6.5

R41.3

ICD-10 Finland

Other amnesia

1.9

6.4

383

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

3.5

6.4

SPAT1211

SPAT

Application of soft bandage

1.5

6.4

228

1603

AAF10

NOMESCO Finland

Lumboperitoneal shunt

70.0

6.4

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

6.4

232

1637

B02.9

ICD-10 Finland

Zoster without complication

1.6

6.4

161

1054

N86

ICPC

Multiple sclerosis

3.3

6.4

AAF50

NOMESCO Finland

Third ventriculostomy

14.3

6.4

H02AB02

ATC

dexamethasone; systemic

1.4

6.4

283

2071

R01AD08

ATC

fluticasone; nasal

1.2

6.4

819

6924

R13

ICD-10 Finland

Dysphagia

1.5

6.4

177

1185

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.2

6.3

216

H65.2

ICD-10 Finland

Chronic serous otitis media

2.5

6.3

160

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

6.3

216

1507

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

6.3

687

5701

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

6.3

369

2823

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.4

6.3

179

G04BD07

ATC

tolterodine; oral

1.7

6.3

117

712

N06AB06

ATC

sertraline; oral

1.4

6.3

307

2284

Z43.0

ICD-10 Finland

Attention to tracheostomy

9.3

6.3

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.4

6.3

167

49300

ICD-8 Finland

Asthma, bronchiale

2.0

6.3

317

G36.0

ICD-10 Finland

Neuromyelitis optica [Devic]

18.0

6.3

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

2.1

6.3

290

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

6.3

100

584

G05.0

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere

+∞

6.2

N16.4*M32.1

ICD-10 Finland

Renal tubulo-interstitial disorders in systemic lupus erythematosus

+∞

6.2

3238X

ICD-9 Finland

Encephalitis, myelitis and encephalomyelitis, Other causes of encephalitis[ENCEPHALITIS (MYELITIS, ENCEPHALOMYELITIS) ALIA DEF]

+∞

6.2

32408

ICD-8 Finland

Late effects of intracranial abscess or pyogenic infection, Alia definitae

+∞

6.2

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.0

6.2

345

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

6.2

291

2148

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

6.2

241

1722

1541, ,

Kela drug reimbursment

26.7

6.2

3069, ,

Kela drug reimbursment

26.7

6.2

R25.2

ICD-10 Finland

Cramp and spasm

2.0

6.2

318

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.1

6.2

284

Q07.0

ICD-10 Finland

Arnold-Chiari syndrome

7.0

6.2

A10AB01

ATC

insulin (human); parenteral

1.7

6.2

563

TKC22

NOMESCO Finland

Catheterisation instruction

2.1

6.2

285

L04AD01

ATC

ciclosporin; systemic

2.1

6.2

265

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

6.3

6.2

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

2.9

6.1

N06AX17

ATC

milnacipran; oral

2.7

6.1

121

L03AB07

ATC

interferon beta-1a; parenteral

3.2

6.1

UDC00

NOMESCO Finland

Ear microscopy

1.5

6.1

190

1302

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.6

6.1

143

922

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

6.1

375

2892

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

6.1

148

963

B01AC04

ATC

clopidogrel; oral

1.3

6.1

383

2964

78020

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Convulsions

2.6

6.1

122

M35.1

ICD-10 Finland

Other overlap syndromes

3.6

6.0

M00.0

ICD-10 Finland

Staphylococcal arthritis and polyarthritis

6.7

6.0

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.0

6.0

315

TK810

NOMESCO Finland

Hemofiltration

3.5

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

728

614

14.68

307.65

1.7

1.2

3.49

3.81

mmol/l

6.32

690

577

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

638

615

12.44

307.65

1.9

1.4

753.86

1384.02

e6/l

0.57

509

499

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

407

135

33.94

307.65

1.3

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

224

29.10

307.65

1.3

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

411

125

37.08

307.65

1.3

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

522

229

26.58

307.65

1.9

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

758

696

13.60

307.65

1.8

1.3

882.08

497.92

mg/l

20.17

738

658

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

374

266

15.61

307.65

1.1

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

654

566

13.95

307.65

1.9

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

260

31.45

307.65

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

342

280

13.42

307.65

1.8

1.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

306

213

15.63

307.65

1.9

1.2

3.05

1.95

mmol/l

9.17

295

203

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

332

114

32.04

307.65

1.8

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

437

277

17.86

307.65

1.7

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

637

615

12.42

307.65

1.9

1.4

217.36

18.64

e6/l

5.06

497

473

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

208

22.96

283.43

1.2

1.1

353.81

632.68

ng/l

0.34

106

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

183

29.19

273.02

1.3

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

187

27.37

272.80

1.3

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

171

32.04

263.09

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

181

25.72

258.29

1.3

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

175

27.84

257.03

1.3

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

159

23.40

219.12

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

217

183

12.57

216.93

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

130

30.63

197.58

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

153

17.34

184.56

1.1

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

214

235

9.63

178.06

1.4

1.1

63.63

41.99

mg/l

4.22

189

191

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

640

1968

3.75

176.40

2.7

2.4

28.98

21.73

au/ml

0.57

172

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

597

1801

3.79

168.81

1.5

1.3

62.16

49.38

au/ml

0.59

107

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

200

219

9.62

166.67

1.2

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

203

227

9.43

166.50

1.2

1.1

370.96

274.76

mg/l

2.52

184

193

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

179

182

10.31

157.42

1.9

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

32.82

153.87

1.3

1.1

—

(3023368) Bacteria identified in Blood by Culture

1408

7215

2.58

153.80

6.0

4.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

249

412

6.43

145.03

1.2

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

164

167

10.25

143.98

1.3

1.1

1.12

1.11

u/l

0.05

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

28.68

141.50

1.3

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

38.61

135.02

1.3

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

144

136

10.99

133.18

1.8

1.2

57.93

67.60

0.56

(3005719) IgG [Mass/volume] in Serum or Plasma

611

2163

3.21

132.42

3.5

2.7

10.16

10.47

g/l

0.96

575

1983

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

203

299

7.14

131.94

1.6

1.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

29.70

131.11

1.2

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

26.21

118.42

1.9

1.2

55.83

42.00

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

23.87

117.18

1.2

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

24.26

116.50

1.2

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

29.79

110.13

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

22.13

105.61

1.4

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

101

12.06

99.85

1.5

1.1

24.57

21.22

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

295

789

3.99

97.14

1.2

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

187

359

5.44

92.82

6.1

6.6

10.70

11.50

mg/l

1.32

173

332

(3028679) Herpes simplex virus Ab [Presence] in Serum

122

150

8.39

92.50

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

866

4316

2.33

92.40

2.0

1.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1357

8127

2.09

90.95

2.8

2.1

192.36

231.61

u/l

0.75

1313

7657

(3018677) aPTT in Platelet poor plasma by Coagulation assay

825

4147

2.29

85.46

2.3

2.2

29.24

29.82

1.93

806

4024

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

23.85

85.10

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

223

536

4.37

84.57

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

13.67

84.50

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

102

120

8.72

80.08

1.2

—

(3001604) Monocytes [#/volume] in Blood

2002

14237

1.94

78.07

9.2

5.9

0.59

0.58

e9/l

2.15

1777

12376

(3006315) Basophils [#/volume] in Blood

2003

14259

1.94

77.72

9.2

5.9

0.04

e9/l

0.05

1775

12385

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

25.60

75.89

1.0

—

(3006504) Eosinophils/100 leukocytes in Blood

1892

13331

1.90

74.48

9.6

6.1

2.72

2.82

1.17

1806

12518

(3013115) Eosinophils [#/volume] in Blood

2042

14756

1.91

74.28

9.6

6.1

0.19

e9/l

0.20

1821

13014

(3019198) Lymphocytes [#/volume] in Blood

2031

14671

1.91

73.74

9.2

6.0

1.95

1.94

e9/l

0.07

1839

13049

(3022096) Basophils/100 leukocytes in Blood

1844

12917

1.90

73.58

9.6

6.2

0.65

0.67

1.30

1755

12106

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

145

274

5.48

73.12

1.6

1.9

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

26.68

72.63

1.0

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

219

582

3.95

72.42

2.6

3.1

29.46

36.64

umol/l

3.46

199

533

(3019069) Monocytes/100 leukocytes in Blood

1890

13414

1.88

71.67

10.0

6.4

8.56

8.55

0.02

1805

12612

(3002030) Lymphocytes/100 leukocytes in Blood

1930

13823

1.87

70.76

9.6

6.2

27.29

28.31

3.61

1843

13033

(3011412) CD3 cells [#/volume] in Blood

143

275

5.38

70.73

2.5

1.31

1.24

e9/l

0.35

127

248

(3013826) Glucose [Moles/volume] in Serum or Plasma

2174

16260

1.88

68.53

7.1

4.8

6.63

6.67

mmol/l

0.32

2076

15177

(40760892) CBC W Ordered Manual Differential panel - Blood

1874

13384

1.85

68.43

10.1

6.4

—

(3018010) Neutrophils/100 leukocytes in Blood

1898

13633

1.85

67.80

9.2

6.0

57.67

56.93

1.86

1811

12838

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1869

13425

1.83

66.11

9.3

6.7

1.21

mmol/l

3.51

1617

11453

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

611

2990

2.26

65.79

1.9

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1687

11757

1.83

65.76

6.1

4.9

34.72

35.82

g/l

10.40

1591

10980

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1730

12151

1.83

65.72

8.6

6.1

1.20

1.21

mmol/l

6.58

1605

11132

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

23.80

65.47

1.3

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

262

841

3.28

65.05

2.5

2.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1749

12356

1.82

64.90

14.7

14.3

1.22

1.24

inr

0.42

480

3662

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

24.51

64.79

1.2

1.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

116

199

5.99

64.77

2.5

2.7

520.74

564.02

e6/l

0.30

170

(3013650) Neutrophils [#/volume] in Blood by Automated count

2174

16421

1.84

64.58

12.6

9.1

4.28

4.08

e9/l

3.25

1945

14374

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

114

194

6.04

64.18

2.6

2.7

0.23

0.21

e9/l

0.30

169

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

607

3002

2.23

63.52

2.0

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1949

14326

1.80

62.42

7.7

6.2

10.42

11.54

umol/l

4.66

1857

13630

(3028026) IgM [Mass/volume] in Serum or Plasma

406

1699

2.57

61.82

2.2

1.8

1.27

1.35

g/l

0.26

373

1560

(3042936) Bacteria identified in Isolate by Culture

728

3912

2.08

61.39

2.4

2.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

160

385

4.31

60.42

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

113

213

5.45

57.10

2.3

2.0

76.04

72.93

1.28

108

205

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

239

785

3.19

57.01

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

246

826

3.13

56.53

3.5

1.6

0.22

0.23

g/l

2.03

230

781

(3032352) Blasts [#/volume] in Cerebral spinal fluid

16.20

56.41

1.4

1.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

13.69

53.64

1.5

2.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

104

193

5.52

53.45

2.4

2.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

13.33

52.82

1.4

2.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

246

862

2.99

52.43

3.5

1.6

1.16

1.18

g/l

0.42

230

814

(3033658) Prothrombin time (PT) actual/Normal

1101

7101

1.80

52.41

5.3

4.1

90.50

90.75

0.13

1078

6926

(3003458) Phosphate [Moles/volume] in Serum or Plasma

651

3543

2.03

52.17

7.2

6.3

1.03

1.05

mmol/l

0.60

610

3304

(3012095) Magnesium [Moles/volume] in Serum or Plasma

757

4398

1.92

49.96

4.3

3.7

0.81

0.82

mmol/l

0.99

710

4149

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

407

1935

2.25

45.99

1.9

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

10.79

45.31

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

7.87

45.09

2.3

1.9

218.89

188.50

e6/l

0.25

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

133

6.05

44.96

1.4

1.1

1663.35

1554.57

miu/ml

0.28

133

(3031040) Bacteria [#/volume] in Urine by Automated count

2270

18317

1.67

44.25

6.1

4.3

5318.23

1649.16

e6/l

0.51

251

(3002582) Erythrocytes [#/volume] in Urine

1206

8321

1.68

43.32

4.3

3.2

35.99

87.81

e6/l

3.04

954

6360

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

11.71

42.96

1.3

1.2

—

(4062490) Immunoglobulin typing, IgG

115

279

4.23

42.94

1.5

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2574

21568

1.71

42.50

11.0

7.4

78.79

77.58

u/l

0.82

2476

20398

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

222

827

2.80

42.18

1.3

—

(3003396) Base excess in Arterial blood by calculation

551

3031

1.97

42.08

10.3

7.8

1.17

1.08

mmol/l

0.23

443

2374

(3006245) CD3-CD19+ cells/100 cells in Blood

106

6.52

41.74

2.5

2.0

9.68

10.41

0.17

100

(3030467) Casts [#/volume] in Urine by Automated count

1115

7613

1.68

41.24

4.2

3.1

0.28

0.40

e6/l

2.26

871

5761

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

549

3043

1.95

40.92

10.4

7.8

5.07

5.10

kpa

0.33

521

2901

(3027801) Oxygen [Partial pressure] in Arterial blood

549

3044

1.95

40.88

10.4

7.8

12.64

12.48

kpa

0.29

521

2905

(3028433) Virus identified in Specimen by Culture

6.88

40.70

1.4

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

112

278

4.13

40.58

1.5

1.4

6.86

6.89

g/l

0.03

193

(46235355) HIV 1 and 2 tests - Meaningful Use set

883

5701

1.73

39.95

1.9

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

111

278

4.09

39.73

1.5

1.4

2.86

2.96

g/l

0.16

194

(3024139) IgG subclass 3 [Mass/volume] in Serum

111

278

4.09

39.73

1.5

1.4

0.34

0.37

g/l

0.46

192

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

332

1543

2.27

39.40

1.8

1.6

—

(3018095) Leukocytes [#/volume] in Urine

1351

9771

1.62

39.34

5.1

3.7

63.91

98.94

e6/l

1.61

998

6859

(36304419) Bacteria [Presence] in Urine

1089

7488

1.66

38.68

4.2

3.0

—

(3026008) Bacteria identified in Urine by Culture

1152

8046

1.64

38.41

3.9

3.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

455

2426

2.00

37.74

8.4

8.1

8.44

9.38

mmol/l

2.42

434

2322

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

533

3013

1.91

37.20

4.2

4.3

247.67

246.23

u/l

0.04

502

2855

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

240

1000

2.50

36.37

2.1

1.8

—

(3026782) Osmolality of Urine

840

5471

1.70

36.30

3.8

2.8

531.74

546.33

mosm/kgh2o

1.14

743

4695

(3037467) Urinalysis macro (dipstick) panel - Urine

2333

19391

1.60

36.29

6.1

4.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

169

590

2.96

36.15

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

169

590

2.96

36.15

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

143

453

3.25

36.12

1.6

1.7

0.59

0.81

g/l

1.81

111

344

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

200

765

2.71

36.08

1.9

2.0

10.93

11.02

mg/l

0.05

184

711

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

276

1230

2.35

36.05

1.9

35.21

39.28

u/l

3.13

250

1097

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

739

4665

1.74

35.71

3.5

2.7

1.12

1.20

e6/l

0.17

425

2610

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

169

595

2.93

35.61

5.1

6.0

394.81

720.87

iu/ml

0.62

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1213

8707

1.60

35.52

2.9

2.6

57.16

67.91

u/l

0.55

1132

8081

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

224

916

2.54

35.30

2.5

2.4

469.62

454.28

ug/l

0.03

212

864

(3007853) Bacteria identified in Skin by Aerobe culture

565

3306

1.84

35.26

2.1

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

9.41

34.46

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

481

2693

1.91

34.40

2.6

2.1

353.42

372.63

nmol/l

1.26

451

2465

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

241

1038

2.42

33.96

2.5

2.0

3.50

2.16

ug/l

0.34

219

917

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

143

479

3.07

32.89

1.4

1.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

433

2381

1.93

32.59

9.0

7.4

1.32

1.38

mmol/l

0.68

417

2319

(3012544) pH of Venous blood

458

2581

1.89

31.97

4.5

4.1

7.41

7.38

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1365

10249

1.54

31.91

4.0

3.5

32.36

46.88

ng/l

1.39

938

6647

(40758558) Short blood count panel - Blood

1019

7163

1.59

31.85

9.2

6.8

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

209

869

2.49

31.78

4.0

1.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2458

20954

1.57

31.77

5.6

4.0

13.56

11.33

mm/h

10.36

2333

19479

(3016502) Oxygen saturation in Arterial blood

474

2714

1.86

31.45

11.3

8.3

95.82

95.76

0.06

459

2612

(3000850) Epithelial cells [#/volume] in Urine

853

5758

1.63

31.45

3.3

2.6

5.98

5.83

e6/l

0.09

783

5157

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

684

4370

1.70

31.16

3.8

2.9

2.60

2.38

e6/l

0.23

370

2328

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

137

464

3.03

30.92

3.4

3.2

958.36

1521.47

u/ml

0.25

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

786

5218

1.65

30.89

3.7

3.6

237.83

463.08

ng/l

2.24

570

3899

(3000991) Gas panel - Venous blood

412

2273

1.92

30.62

10.8

8.9

—

(3003181) Sodium [Moles/volume] in Urine

135

456

3.04

30.61

1.4

1.3

71.08

62.27

mmol/l

1.18

104

361

(3020630) Protein [Mass/volume] in Serum or Plasma

388

2104

1.95

30.34

2.6

66.15

66.48

g/l

0.32

357

1939

(3018418) pH of Serum or Plasma

1095

7897

1.56

30.33

5.1

4.0

7.40

0.14

200

1533

(3002032) Base excess in Venous blood by calculation

441

2504

1.87

29.97

4.7

4.0

1.55

1.96

mmol/l

1.61

387

2084

(3009445) Proteinase 3 Ab [Units/volume] in Serum

252

1168

2.25

29.93

1.4

1.6

18.76

18.05

u/ml

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

443

2522

1.86

29.85

4.6

4.0

5.74

5.85

kpa

1.59

431

2445

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

121

390

3.18

29.72

1.8

1.9

2800.00

1335.00

titre

—

(3024354) Oxygen [Partial pressure] in Venous blood

379

2080

1.92

28.53

3.9

3.4

4.84

4.68

kpa

0.68

366

2014

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1404

10817

1.49

27.97

2.1

1.9

96.62

95.71

pmol/l

0.25

742

5720

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

322

1705

1.98

26.88

10.7

8.2

24.61

24.85

mmol/l

0.57

315

1694

(3002173) Hemoglobin [Mass/volume] in Arterial blood

432

2518

1.82

26.84

12.1

8.6

119.95

122.76

g/l

2.01

422

2446

(3044640) Blood type and Crossmatch panel - Blood

1177

8807

1.50

26.73

2.9

2.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

209

948

2.28

26.11

1.5

1.6

394.00

274.21

titre

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

269

1355

2.07

25.79

5.6

4.5

23.72

24.13

mmol/l

1.42

263

1331

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

890

6313

1.55

25.78

1.8

1.19

1.09

mg/l

0.48

693

4745

(3019309) Folate [Moles/volume] in Red Blood Cells

706

4762

1.60

25.40

1.8

1.7

1117.89

1165.32

nmol/l

0.72

551

3635

(3007164) IgA [Mass/volume] in Serum or Plasma

814

5682

1.56

25.25

1.8

1.5

2.34

2.37

g/l

0.18

563

3544

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

141

549

2.63

24.56

1.6

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

599

3913

1.64

24.47

1.5

1.3

600.26

527.89

titre

0.38

151

796

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

293

3.27

24.43

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

5.16

24.27

2.7

3.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

270

1398

2.01

23.97

11.7

10.3

24.41

24.34

mmol/l

0.13

258

1361

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

173

3.99

23.91

3.2

2.8

43.25

42.59

0.10

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1446

11450

1.45

23.85

2.6

2.3

75.94

76.36

nmol/l

0.22

1309

10394

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

157

654

2.47

23.77

1.6

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

239

1187

2.09

23.77

1.9

1.8

1.73

1.52

g/l

2.61

206

1030

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1232

9498

1.46

23.27

4.2

3.2

36.63

35.47

u/l

0.12

1164

9028

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

225

1104

2.11

23.10

2.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

118

437

2.76

22.68

4.4

5.4

346.66

369.71

umol/l

1.02

100

386

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

158

675

2.40

22.65

1.5

1.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

887

6446

1.50

22.44

4.4

3.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

194

911

2.19

22.28

1.7

1.6

0.14

0.18

iu/ml

0.16

177

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2268

19639

1.43

22.03

4.3

3.1

53.92

47.32

u/l

2.84

2154

18476

(3004588) Protein electrophoresis panel - Serum or Plasma

308

1721

1.86

21.77

2.6

2.3

—

(3015736) pH of Urine

1409

11236

1.42

21.73

4.4

3.3

5.98

5.85

0.82

104

948

(3021589) Normoblasts [#/volume] in Blood

1558

12662

1.41

21.51

13.1

9.3

0.00

e9/l

0.82

1273

10324

(3008295) Osmolality of Serum or Plasma

306

3.06

21.49

1.5

1.4

284.30

281.13

mosm/kgh2o

0.57

225

(3017143) Hepatitis C virus Ab [Presence] in Serum

543

3581

1.61

21.09

1.7

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

111

4.55

21.00

2.1

2.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

216

1086

2.05

20.78

1.4

1.2

1.45

0.85

u/ml

0.24

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

907

6741

1.46

20.15

2.8

2.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

164

750

2.24

20.10

1.4

1.3

—

(3036489) Thrombin time

216

1103

2.02

19.91

2.3

21.40

21.42

0.01

191

968

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

118

468

2.57

19.84

1.5

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

118

468

2.57

19.84

1.5

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

461

2962

1.64

19.83

2.7

1.73

1.78

0.39

410

2625

(3000494) Fungus identified in Specimen by Culture

507

3340

1.60

19.69

1.6

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.78

19.61

2.6

2.3

188900.00

28593.71

u/ml

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

292

1657

1.83

19.61

11.1

7.2

24.88

24.47

mmol/l

1.18

279

1566

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

928

6968

1.45

19.42

2.5

2.2

3.08

2.91

mg/l

1.06

801

5929

(3035350) Ketones [Presence] in Urine by Test strip

1667

13866

1.38

19.29

4.8

3.5

0.01

0.00

estimate

0.32

315

2766

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

197

3.45

19.16

1.5

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1591

13146

1.38

19.11

3.1

2.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

413

2606

1.66

19.04

2.6

2.3

0.22

g/l

0.02

385

2442

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

258

1424

1.88

18.91

14.0

11.0

—

(3019060) Gas panel - Arterial blood

299

1728

1.80

18.90

8.0

5.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

180

876

2.11

18.89

3.3

3.6

0.31

0.34

u/ml

0.61

101

489

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

414

2632

1.65

18.51

2.6

2.5

65.85

56.68

u/l

0.10

364

2267

(3021601) Nitrite [Presence] in Urine by Test strip

1658

13841

1.37

18.46

6.6

4.8

0.00

estimate

0.50

310

2637

(3009261) Glucose [Presence] in Urine by Test strip

1672

13982

1.37

18.39

4.8

3.5

0.00

estimate

1.32

304

2541

(3023520) Reticulocytes [#/volume] in Blood

354

2168

1.70

18.24

2.6

2.7

67.12

70.82

e9/l

0.88

262

1620

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

134

3.92

18.03

3.1

2.4

47.55

50.59

umol/l

0.31

112

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.98

17.81

1.2

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

112

458

2.49

17.70

1.3

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

298

1759

1.76

17.50

4.6

3.8

5.17

5.16

kpa

0.14

285

1671

(3015377) Calcium [Moles/volume] in Serum or Plasma

1154

9150

1.39

17.34

3.8

3.3

2.34

2.35

mmol/l

1.87

1020

8136

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

116

488

2.42

17.26

1.7

1.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

285

1675

1.76

16.99

4.5

3.8

1.62

1.71

mmol/l

0.17

224

1238

(3009343) pH of Capillary blood

293

1737

1.75

16.94

4.6

3.8

7.41

0.00

211

(3024891) Influenza virus A+B Ag [Presence] in Specimen

166

817

2.08

16.93

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3090

28872

1.56

16.73

24.1

13.4

23.75

23.29

mg/l

0.35

2673

22687

(3008757) Leukocyte morphology finding [Identifier] in Blood

296

2.81

16.62

4.1

4.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

177

902

2.01

16.42

2.5

2.4

10.06

10.20

g/l

0.12

152

813

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

272

1595

1.76

16.33

1.6

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

14.31

16.29

1.0

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

186

970

1.97

16.17

2.7

2.3

7.34

g/l

0.00

161

883

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

186

970

1.97

16.17

2.7

2.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

109

462

2.40

15.97

1.4

1.2

5.09

4.80

u/ml

0.08

205

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

21.03

15.96

1.2

1.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

185

969

1.96

15.88

2.7

2.3

3.82

3.64

g/l

0.42

160

883

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

191

3.23

15.85

1.6

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

797

6014

1.42

15.72

1.7

1.5

20.29

20.36

nmol/l

0.04

709

5185

(3002179) Metamyelocytes/100 leukocytes in Blood

340

2141

1.65

15.70

4.7

4.1

0.57

0.68

0.64

171

676

(3017181) Myelocytes/100 leukocytes in Blood

363

2337

1.62

15.33

5.0

4.3

0.82

0.90

0.32

184

782

(3004809) Band form neutrophils/100 leukocytes in Blood

101

424

2.42

15.14

4.3

3.6

1.26

1.39

0.15

379

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

20.11

15.08

1.1

1.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

178

939

1.94

14.97

2.5

2.6

95.53

91.93

1.17

172

908

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

130

617

2.15

14.60

1.4

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

173

912

1.94

14.59

2.7

2.4

2.87

2.95

g/l

0.50

148

826

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

106

469

2.30

14.13

1.3

1.2

3.26

3.81

u/ml

0.17

154

(3047181) Lactate [Moles/volume] in Blood

161

839

1.96

14.05

10.2

6.7

1.40

1.30

mmol/l

0.69

141

723

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

922

7254

1.37

13.91

3.0

1189.16

1376.60

ng/l

0.47

780

6139

(1761868) Lipid panel - Serum or Plasma

854

10740

0.73

13.87

2.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

343

2231

1.60

13.85

5.0

4.3

0.14

0.11

0.24

165

675

(3004789) Transferrin [Mass/volume] in Serum or Plasma

549

3955

1.46

13.74

2.9

2.5

2.30

2.34

g/l

1.04

519

3662

(3022313) Gas panel - Capillary blood

220

1276

1.77

13.72

4.6

3.9

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

197

1111

1.82

13.49

4.7

4.1

24.90

24.82

mmol/l

0.16

186

1036

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

127

617

2.10

13.46

1.7

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

152

791

1.96

13.33

1.6

1.2

38.17

39.32

u/ml

0.02

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

627

4663

1.42

13.16

1.7

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

157

831

1.93

13.11

2.7

2.5

1.43

0.94

g/l

0.53

132

730

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

330

2.49

13.00

1.2

—

(3039000) Anion gap in Blood

121

586

2.10

12.94

11.9

8.0

11.10

11.38

mmol/l

0.33

110

520

(3018572) Chloride [Moles/volume] in Blood

121

587

2.10

12.88

11.9

8.0

105.31

105.37

mmol/l

0.04

110

521

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

454

3189

1.49

12.87

3.3

2.9

7.39

8.10

umol/l

0.38

374

2787

(3021879) Hepatitis B virus core Ab [Presence] in Serum

350

2326

1.56

12.87

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

187

1055

1.82

12.80

9.2

5.7

0.94

0.90

0.88

176

984

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

130

650

2.04

12.77

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

305

1968

1.60

12.72

4.3

4.1

84.96

86.50

ng/l

0.11

265

1718

(3006653) Thiamine [Moles/volume] in Blood

149

3.25

12.71

1.2

1.3

120.94

137.99

nmol/l

1.98

149

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

146

763

1.95

12.66

2.1

2.3

36.53

37.76

g/l

1.14

121

676

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

160

863

1.89

12.63

3.2

2.9

3.85

3.57

g/l

1.14

154

816

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

512

3698

1.45

12.57

3.0

2.6

20.98

23.52

3.23

445

3184

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

324

2.47

12.51

1.5

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

324

2.47

12.51

1.5

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

349

2.41

12.46

2.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

260

2.65

12.44

3.9

3.6

56.18

55.19

0.14

225

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

13.19

12.41

1.3

1.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

581

4306

1.42

12.37

2.9

2.5

12.25

13.55

umol/l

3.59

552

4018

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

11.64

12.29

1.5

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

141

736

1.95

12.28

2.3

0.03

0.02

g/l

0.21

124

681

(3005322) IgE [Units/volume] in Serum or Plasma

293

1892

1.60

12.18

1.4

1.3

234.61

214.79

u/ml

0.13

275

1745

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

186

1065

1.79

12.14

9.1

5.7

1.84

1.65

1.37

174

992

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.05

12.10

2.2

1.9

—

(3025159) Blasts/100 leukocytes in Blood

321

2121

1.56

12.09

4.9

4.3

0.65

0.38

0.18

141

562

(3019550) Sodium [Moles/volume] in Serum or Plasma

3091

29240

1.46

12.06

25.5

15.1

139.31

139.66

mmol/l

11.61

3047

28507

(3010838) Calcium [Moles/time] in 24 hour Urine

102

477

2.17

11.95

1.8

1.9

4.63

5.12

mmol/24h

0.71

420

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1467

12542

1.29

11.87

3.2

2.8

131.49

122.04

ug/l

0.69

1353

11671

(3019225) pH of Specimen

378

2603

1.51

11.78

5.0

4.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

256

1614

1.63

11.74

3.8

3.3

125.22

129.75

g/l

2.67

250

1570

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

417

2.24

11.65

1.3

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

241

2.64

11.54

1.4

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

139

740

1.91

11.44

1.6

1.2

6.56

8.54

u/ml

0.27

125

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

137

727

1.92

11.39

1.6

1.2

11.86

7.07

u/ml

0.35

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

296

2.46

11.38

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

168

957

1.79

11.17

1.4

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

178

2.89

11.11

1.3

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

368

2.29

11.09

1.3

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

113

569

2.02

10.94

1.5

92.88

114.11

u/ml

0.93

102

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

115

583

2.01

10.92

1.6

1.2

3.52

3.61

u/ml

—

(3023420) DNA double strand Ab [Units/volume] in Serum

290

2.44

10.90

2.5

1.5

22.40

26.37

iu/ml

—

(3052851) Hemolysis interference index of Serum or Plasma

147

814

1.84

10.73

3.6

3.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

414

2956

1.45

10.73

1.5

1.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3089

29336

1.42

10.65

25.5

15.2

3.96

mmol/l

0.73

3036

28546

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

152

855

1.81

10.55

2.7

2.8

201.72

184.64

1.35

144

818

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

129

689

1.91

10.54

2.2

2.4

0.00

g/l

-0.00

112

636

(40761535) Cells panel - Urine sediment

329

2252

1.51

10.53

4.4

3.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

171

997

1.75

10.52

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

110

560

2.00

10.34

3.1

3.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

243

2.54

10.33

1.4

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

243

2.54

10.33

1.4

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

243

2.54

10.33

1.4

1.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

137

753

1.85

10.26

3.4

3.5

57.23

71.03

mg/l

0.20

115

607

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

127

683

1.89

10.18

2.2

2.4

0.00

g/l

-0.00

111

635

(3019150) Specific gravity of Urine by Refractometry

766

6103

1.33

10.16

5.2

3.8

1.02

kg/l

0.64

131

873

(3027273) Bicarbonate [Moles/volume] in Venous blood

201

1240

1.66

10.06

3.5

3.3

25.48

25.31

mmol/l

0.28

193

1200

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

118

622

1.93

10.05

1.3

289.64

268.96

u/ml

0.25

379

(3034860) Kappa light chains.free [Mass/volume] in Serum

136

751

1.84

10.04

3.4

3.5

45.11

62.16

mg/l

0.84

113

603

(3036180) Methadone [Presence] in Urine

150

2.96

10.02

2.4

3.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

133

730

1.85

10.01

3.4

3.5

6.79

1.56

ratio

0.63

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

628

4871

1.35

9.97

3.5

3.0

2.45

mmol/l

0.01

537

4276

(3037121) Protein [Mass/volume] in Urine

165

974

1.73

9.74

4.3

3.3

0.20

0.35

g/l

1.84

420

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

511

3850

1.38

9.73

1.7

1.8

1.53

1.46

1.26

448

3438

(3037756) Immunofixation for Serum or Plasma

102

517

2.00

9.73

1.5

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.19

9.62

1.4

2.0

—

(40768804) Tissue Pathology biopsy report

1321

11359

1.26

9.56

2.1

2.0

—

(3024928) Oxygen saturation in Venous blood

111

584

1.93

9.52

3.7

3.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

388

2.14

9.41

1.6

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

390

2821

1.43

9.39

4.2

3.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

890

7306

1.29

9.37

3.1

2.6

1776.61

4632.57

umol/l

2.46

789

6452

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

116

624

1.89

9.32

1.2

—

(1616796) Gas panel - Central venous blood

113

604

1.90

9.26

5.7

3.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

321

2249

1.47

9.15

2.4

2.3

5.77

7.19

ug/l

1.09

275

2001

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

315

2.25

9.10

1.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

111

594

1.90

9.07

1.6

1.2

23.59

45.00

u/ml

1.42

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

3.35

9.02

3.7

2.8

32.75

29.77

umol/l

0.43

(3012501) Base excess in Blood by calculation

116

631

1.87

9.01

6.9

4.4

2.73

2.54

mmol/l

0.29

421

(3016038) Potassium [Moles/volume] in Urine

171

2.71

8.98

1.3

1.2

37.41

34.55

mmol/l

0.26

155

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

110

589

1.90

8.97

1.4

—

(3013290) Carbon dioxide [Partial pressure] in Blood

116

632

1.86

8.97

6.9

4.4

4.96

5.03

kpa

0.41

108

622

(3017732) Neutrophils [#/volume] in Blood

285

1959

1.49

8.94

3.4

2.9

6.06

5.31

e9/l

0.21

220

1623

(4035726) Immunohistochemistry procedure

333

2362

1.45

8.91

1.5

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

116

634

1.86

8.89

6.9

4.4

8.47

8.62

kpa

0.42

108

623

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

379

2.11

8.78

1.4

1.5

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

9.48

8.76

1.6

1.3

1.42

3.32

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

9.48

8.76

1.6

1.3

0.29

1.36

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

9.48

8.76

1.6

1.3

2.15

0.79

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

9.48

8.76

1.6

1.3

2.66

3.25

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

9.48

8.76

1.6

1.3

1.46

2.51

mg/l

0.24

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

9.48

8.76

1.6

1.3

2.65

5.79

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

9.48

8.76

1.6

1.3

1.26

4.78

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

9.48

8.76

1.6

1.3

3.00

2.29

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

9.48

8.76

1.6

1.3

1.72

2.03

mg/l

—

(3010421) pH of Blood

132

755

1.78

8.73

6.5

4.1

7.42

0.21

111

674

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

147

2.81

8.58

1.4

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

147

2.81

8.58

1.4

2.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

8.98

8.52

1.6

1.4

0.57

2.03

mg/l

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

12.77

8.36

1.5

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

103

560

1.86

8.06

5.2

3.8

57.32

57.49

0.05

103

560

(3035637) Corticotropin [Mass/volume] in Plasma

345

2.11

8.05

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

496

1.92

8.05

1.1

—

(3020891) Body temperature

172

1081

1.62

8.05

6.9

4.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

133

785

1.72

7.91

1.9

1.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2370

21983

1.24

7.85

4.4

3.9

14.76

14.70

pmol/l

0.48

2189

20140

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

132

2.82

7.84

1.9

1.6

394595.71

1452875.00

iu/ml

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

310

2.15

7.78

2.5

2.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2133

19581

1.23

7.74

3.3

3.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

117

2.92

7.69

1.4

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

117

2.92

7.69

1.4

2.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

118

2.90

7.58

1.5

2.2

—

(3051651) Icteric interference index of Serum or Plasma

170

2.55

7.49

4.2

3.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

176

2.52

7.48

1.1

1.0

340.97

286.10

ng/l

0.38

113

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2843

26973

1.28

7.44

19.2

12.3

85.11

83.86

ml/min/173m2

2.10

2474

22246

(3051611) Lipemic interference index of Serum or Plasma

271

2.20

7.37

3.8

3.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

154

2.62

7.35

8.4

7.1

3624.54

53.78

u/ml

0.47

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2772

26257

1.26

7.12

5.2

4.6

1.82

2.08

mu/l

2.01

2566

24269

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

175

2.47

7.07

1.1

1.0

696.79

736.59

ng/l

0.21

112

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

441

1.90

7.01

1.2

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

201

2.36

6.95

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

201

2.36

6.95

1.3

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

147

2.60

6.94

1.2

1.1

23.09

17.17

u/l

0.47

124

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

177

2.45

6.91

1.1

1.0

39.80

43.11

ng/l

0.22

110

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

501

1.84

6.90

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

202

2.34

6.88

1.3

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

102

583

1.77

6.84

5.6

3.3

—

(3024316) Viscosity of Plasma

8.26

6.82

1.1

1.2

1.35

1.78

mpas

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

229

2.24

6.76

1.2

330.00

140.00

titre

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

199

2.33

6.65

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

199

2.33

6.65

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

199

2.33

6.65

1.3

1.1

—

(40758292) HTLV I+II Ab panel - Serum

3.81

6.52

1.2

1.4

—

(3025941) Bacteria identified in Stool by Culture

234

1653

1.44

6.43

1.3

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

153

2.50

6.42

1.2

1.1

93.59

87.02

u/l

0.14

132

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

267

2.11

6.42

2.5

2.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

292

2154

1.39

6.29

2.7

2.9

182.57

189.17

ng/l

0.09

260

1936

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

688

5716

1.25

6.26

1.6

1.7

46440581.55

30014949.26

pmol/l

0.24

618

4821

(3039162) Centromere protein B Ab [Units/volume] in Serum

352

1.95

6.25

1.8

1.3

85.68

51.17

u/ml

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1221

10765

1.21

6.23

5.2

3.7

—

(3023419) Bacteria identified in Sputum by Culture

404

1.87

6.13

3.1

2.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

188

2.30

6.09

1.0

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

127

796

1.62

6.09

1.4

247.80

289.46

ug/g

1.47

455

(40765096) Chromosome analysis panel by Banding

3.03

6.06

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

100

596

1.70

5.84

2.5

2.3

132.60

131.20

g/l

0.18

437

(1001926) Buprenorphine [Presence] in Urine by Screen method

156

1038

1.53

5.80

4.2

2.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

143

2.46

5.77

1.5

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

568

1.71

5.76

3.2

2.6

16.74

16.55

0.13

288

(3003327) Ova and parasites identified in Stool by Light microscopy

147

969

1.54

5.71

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

280

2.02

5.70

1.1

1.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

214

2.16

5.65

1.3

1.2

97.67

31.90

u/ml

—

(3009508) Creatinine [Moles/volume] in Urine

985

8578

1.21

5.61

4.0

3.3

7.64

7.76

mmol/l

0.32

833

7349

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.19

5.59

2.6

2.1

18.82

16.61

umol/l

0.33

(3042631) Mycobacterium sp identified in Specimen

353

1.89

5.55

2.1

2.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

332

1.91

5.54

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

332

1.91

5.54

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

146

2.41

5.53

1.5

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

216

2.14

5.53

1.2

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

216

2.14

5.53

1.3

1.2

13.00

42.42

u/ml

—

(3029937) Albumin [Presence] in Urine by Test strip

865

7458

1.21

5.45

5.4

3.9

0.00

estimate

1.28

291

2537

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

241

1765

1.39

5.45

3.1

3.3

4.39

4.50

pmol/l

0.79

208

1576

(3005988) Vibrio sp identified in Specimen by Organism specific culture

334

1.90

5.44

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

194

1373

1.44

5.33

3.4

2.8

0.22

0.29

e6/l

0.72

189

1333

(3011985) Renin [Units/volume] in Plasma

351

1.87

5.32

1.3

1.4

50.80

52.50

mu/l

0.05

311

(3004616) Nuclear Ab [Presence] in Serum

344

1.88

5.31

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

337

1.88

5.31

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

302

1.94

5.29

4.0

5.9

7.78

7.35

mmol/l

0.20

259

(3020191) Ethanol [Moles/volume] in Serum or Plasma

251

2.01

5.08

1.2

1.5

0.73

1.31

promille

2.72

194

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

445

1.75

5.07

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

113

723

1.58

5.04

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

124

811

1.55

5.03

1.2

1.3

111.25

90.74

titre

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

266

1.97

5.01

1.2

56.09

63.80

u/l

0.53

243

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

123

804

1.55

5.00

5.6

4.3

1.61

1.47

mg/l

0.96

116

749

(3017446) Testosterone [Moles/volume] in Serum or Plasma

301

2317

1.33

4.96

2.3

2.2

12.63

13.09

nmol/l

0.40

268

2103

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.89

4.95

1.4

5.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.87

4.92

1.9

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

333

1.85

4.86

1.5

—

(3021901) Oxygen saturation in Capillary blood

490

1.69

4.81

4.1

2.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

461

1.71

4.77

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

336

1.83

4.73

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

584

4909

1.23

4.69

1.4

1.3

24.04

30.10

iu/ml

0.79

180

1581

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

420

1.73

4.62

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.34

4.60

2.2

1.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.13

4.60

1.7

3.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

100

637

1.59

4.58

1.8

1.7

11911.23

13820.61

e6/l

0.27

462

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

14.02

4.57

1.1

1.2

2.55

1.20

mg/l

—

(3013336) Amino acids [Identifier] in Serum or Plasma

8.20

4.56

3.0

4.8

—

(40768443) Skin Pathology biopsy report

161

1138

1.43

4.50

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

593

1.60

4.49

1.4

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

215

2.01

4.45

1.5

1.7

—

(40761511) CBC panel - Blood by Automated count

3104

30131

1.25

4.42

19.5

12.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

481

1.66

4.35

1.2

1.1

16333.44

1152.63

iu/ml

0.44

119

(3033086) Enterovirus NOS Ab [Titer] in Serum

7.52

4.35

1.1

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

256

1964

1.33

4.35

1.2

140.83

154.18

iu/ml

0.18

725

(3048689) Calprotectin [Mass/mass] in Stool

436

3583

1.25

4.31

2.6

2.4

169.95

131.43

ug/g

0.77

354

2878

(40768797) Stomach Pathology biopsy report

464

3840

1.24

4.31

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3153

30685

1.26

4.22

15.3

9.9

27.99

27.01

u/l

1.63

3078

29708

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

269

1.87

4.21

4.2

3.7

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

255

1.89

4.20

1.9

2.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.15

4.20

4.9

6.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

141

986

1.45

4.20

1.3

186.16

221.65

miu/ml

0.53

468

(3020876) Protein [Mass/time] in 24 hour Urine

277

1.85

4.18

2.7

2.5

1.68

g/24h

0.00

139

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

126

867

1.47

4.09

1.3

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

131

909

1.46

4.07

1.7

1.4

10.35

9.34

u/l

0.34

110

740

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

209

1.97

4.06

1.2

—

(21494755) Public health laboratory ask at order entry panel

249

3189

0.76

4.05

1.4

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

129

2.26

4.05

1.9

1.7

4.52

7.93

nmol/l

0.38

109

(40768446) Kidney Pathology biopsy report

117

2.32

4.01

2.0

1.7

—

(3034426) Prothrombin time (PT)

2.43

3.96

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

112

2.33

3.91

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

112

2.33

3.91

1.4

—

(3016879) Cocaine [Presence] in Urine

168

1229

1.39

3.90

4.2

2.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

178

2.03

3.88

1.2

1.1

1.06

1.05

ratio

0.21

(3047007) Chlamydophila sp Ab [Presence] in Serum

435

1.64

3.86

1.1

1.2

—

(3013512) EKG study

868

7691

1.17

3.85

4.2

3.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

256

1.85

3.84

1.8

2.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

126

880

1.45

3.81

1.3

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.19

3.77

1.1

1.2

—

(3021788) Differential panel - Synovial fluid

485

1.60

3.76

1.6

—

(3022621) pH of Urine by Test strip

232

1794

1.31

3.76

3.3

2.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

125

874

1.45

3.76

1.3

1.2

—

(3012441) Differential panel - Pleural fluid

251

1.84

3.75

1.4

—

(3012516) Albumin [Mass/volume] in Urine

877

7793

1.17

3.73

3.7

3.3

937.77

334.52

mg/l

1.77

596

5025

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

740

6492

1.18

3.69

1.3

2.34

1.61

u/ml

0.42

173

1738

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.69

3.65

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

156

2.06

3.60

1.0

1.2

10.15

12.18

u/l

0.54

146

(3023199) Leukocytes [#/volume] in Pleural fluid

299

1.75

3.59

1.3

1.4

2416.95

1873.35

e6/l

0.28

216

(36660697) Celiac disease serology panel - Serum

289

2315

1.27

3.58

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.95

3.57

1.6

1.4

0.34

0.36

ug/l

—

(3000764) Benzodiazepines [Presence] in Urine

176

1318

1.35

3.56

4.1

2.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

330

1.71

3.55

1.5

1.6

55.76

59.54

0.27

213

(3003434) Protein [Mass/volume] in Pleural fluid

315

1.73

3.55

1.3

1.4

30.93

32.00

g/l

0.21

281

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

105

2.29

3.52

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

264

1.79

3.51

1.3

1.4

41108.66

89906.20

e6/l

0.71

159

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

131

2.15

3.51

3.1

1.8

29.64

29.52

umol/l

0.02

126

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.01

3.49

6.3

5.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.62

3.46

1.4

1.2

—

(3027008) Opiates [Presence] in Urine

176

1325

1.35

3.45

4.0

2.2

—

(3045414) Leukocytes [Presence] in Urine

167

1248

1.35

3.44

2.0

1.8

—

(4200892) Spirometry reversibility

246

1945

1.28

3.40

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

646

5641

1.18

3.40

1.7

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

202

1.89

3.38

1.8

1.7

—

(3028300) Cannabinoids [Presence] in Urine

176

1330

1.34

3.38

4.1

2.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

272

2185

1.27

3.31

5.8

3.7

1.21

1.23

mmol/l

3.30

248

1906

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

108

2.23

3.31

1.1

—

(3045788) Cell count panel - Pleural fluid

240

1.80

3.30

1.3

1.4

—

(3045424) Erythrocytes [Presence] in Urine

478

1.56

3.29

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

142

2.05

3.26

2.2

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

142

2.05

3.26

2.2

1.7

—

(3027944) Amphetamines [Presence] in Urine

172

1303

1.34

3.26

3.6

2.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

146

1951

0.74

3.25

1.3

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

198

1.88

3.24

1.8

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2682

25876

1.15

3.18

6.0

5.4

39.86

39.43

mmol/mol

1.32

2503

24128

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

130

2.08

3.17

1.8

2.8

90.00

144.99

umol/l

0.63

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

124

2.10

3.13

1.3

1.1

293.06

201.62

iu/ml

0.38

124

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.26

3.13

1.1

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

102

715

1.44

3.09

2.5

2.3

—

(3044009) aPTT.lupus sensitive (LA screen)

3.67

3.08

1.3

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

106

2.18

3.02

1.3

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

906

8183

1.14

3.01

4.4

3.9

16.53

9.35

mg/mmol

2.02

607

5242

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

393

3321

1.21

3.00

8.7

6.7

—

(3019174) dRVVT (LA screen)

3.56

2.98

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.24

2.96

1.7

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

275

2244

1.24

2.95

2.9

2.5

67.25

68.18

ml/min/173m2

0.06

110

853

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

333

1.63

2.94

1.4

2294.69

312.11

pmol/l

0.50

291

(3041096) Erythrocytes [Presence] in Urine by Automated

847

7631

1.14

2.91

4.5

3.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

274

1.69

2.87

2.8

4.6

27.55

81.23

u/ml

1.14

(3013293) Extractable nuclear Ab [Presence] in Serum

2.77

2.81

2.8

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

123

2.04

2.81

1.0

1.1

—

(3044889) 12 lead EKG panel

2063

19647

1.12

2.79

3.9

3.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

234

2877

0.80

2.78

1.6

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

189

1.81

2.70

1.1

0.11

4.06

nmol/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.51

2.70

1.4

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

180

1413

1.29

2.69

2.7

2.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.76

2.67

1.4

1.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

126

1.99

2.65

1.0

1.1

9.25

7.17

u/ml

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

304

1.62

2.64

3.0

2.5

—

(3020393) Adenovirus Ag [Presence] in Stool

3.15

2.64

1.8

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

429

3703

1.18

2.60

2.3

2.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

207

1.75

2.57

1.2

1.3

242.77

336.78

u/l

0.82

200

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.01

2.56

1.6

4.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.06

2.56

1.1

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

200

1.76

2.55

1.3

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

7.15

2.55

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.23

2.53

5.8

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.23

2.53

5.8

2.8

—

(3011288) Drugs identified in Urine by Screen method

121

911

1.34

2.47

5.4

3.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

203

1.73

2.44

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

167

1318

1.28

2.42

5.1

3.3

—

(3002385) Erythrocyte distribution width [Ratio]

2589

25067

1.12

2.41

26.0

15.9

14.99

14.92

0.12

2559

24605

(3041354) Potassium [Moles/volume] in Venous blood

312

1.58

2.41

3.0

2.5

4.09

4.05

mmol/l

0.37

307

(3035285) Chloride [Moles/volume] in Venous blood

312

1.58

2.41

3.0

2.5

106.18

105.37

mmol/l

0.46

307

(3009677) Dengue virus Ab [Presence] in Serum

5.01

2.40

1.2

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

117

1.97

2.40

2.3

2.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

387

3337

1.18

2.39

2.1

2.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

146

1135

1.30

2.39

2.1

2.3

1805.46

4553.86

u/l

2.13

434

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

701

1.38

2.38

1.6

1.9

4.78

4.54

iu/l

0.09

255

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

377

1.52

2.37

1.9

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

530

4687

1.15

2.37

1.3

1.2

5.77

10.42

u/ml

1.94

195

1890

(3010144) Erythrocytes [#/volume] in Synovial fluid

252

1.63

2.33

1.3

1.4

76905.10

88563.73

e6/l

0.05

172

(3029075) Extractable nuclear Ab panel - Serum

2.18

2.30

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.12

2.28

1.3

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

430

1.47

2.27

1.5

1.4

22.51

24.97

u/l

0.28

350

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.62

2.27

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.48

2.27

1.4

2.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

127

1.90

2.25

3.5

3.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

334

1.53

2.24

2.4

2.2

19.71

23.88

mg/l

0.37

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

379

3282

1.17

2.23

4.4

4.3

31.86

31.97

0.06

271

2313

(3035880) pH of Pleural fluid

128

1.88

2.21

1.1

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

121

930

1.31

2.18

3.4

3.6

403.37

4554.47

u/ml

0.78

105

792

(3014271) Vancomycin [Susceptibility]

115

1.92

2.15

3.7

2.9

—

(3024471) HLA-A [Type]

108

1.95

2.15

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

3.00

2.14

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.78

2.13

4.4

7.7

32.50

42.85

ug/min

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

537

1.41

2.12

3.0

3.4

116.01

802.24

u/ml

0.82

501

(3032057) Clostridioides difficile [Presence] in Stool

2.37

2.12

2.2

2.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

182

1.71

2.11

1.4

1.5

—

(3019977) pH of Arterial blood

145

1.80

2.10

4.7

2.8

7.42

—

(3052592) Norovirus Ag [Presence] in Stool

2.56

2.07

1.9

1.5

—

(3011648) Oxygen content in Venous blood

237

1.61

2.07

2.0

3.4

10.96

11.41

0.29

237

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.00

2.07

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.91

2.07

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.18

2.04

3.1

2.9

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

141

1117

1.27

2.04

1.8

1.6

300.92

295.32

mu/l

0.09

131

1007

(3042111) Morphology [Interpretation] in Bone marrow Narrative

442

1.43

2.01

1.9

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

155

1.75

2.00

1.4

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

155

1.75

2.00

1.4

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

308

2651

1.18

1.98

3.7

4.1

8.34

21.72

ug/l

1.46

235

2146

(40757494) Bilirubin.total [Moles/volume] in Blood

148

1.76

1.98

2.1

2.2

49.80

32.30

umol/l

—

(3042733) HLA Ab [Presence] in Serum

112

1.88

1.96

6.7

5.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

511

0.62

1.95

1.7

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.75

1.93

1.5

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.73

1.93

1.2

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

106

1.89

1.90

1.3

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.92

1.90

1.3

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.96

1.89

1.1

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.31

1.87

1.1

1.2

84.12

70.33

ug/l

—

(3004451) EKG impression Narrative

129

1.79

1.85

1.1

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

3.53

1.83

1.0

—

(3022145) Colonoscopy Study observation

353

3093

1.16

1.82

1.5

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.17

1.82

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

4.17

1.82

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

343

1.46

1.82

1.2

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

361

1.45

1.79

1.2

1.3

—

(3044941) Cell count panel - Synovial fluid

428

1.41

1.78

1.7

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

1.88

1.70

1.8

1.4

—

(3025130) Human papilloma virus identified in Specimen

382

1.42

1.69

2.1

1.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

111

1.81

1.68

1.2

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

520

1.35

1.66

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

520

1.35

1.66

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

112

1.79

1.64

3.3

2.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

112

1.79

1.64

1.1

1.2

—

(3017704) Immunofixation for Urine

150

1.67

1.63

1.5

—

(21494434) Karyotype in Bone marrow

237

1.52

1.62

1.3

1.2

—

(3047189) Immunofixation for 24 hour Urine

120

1.75

1.62

1.4

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

612

1.31

1.57

1.5

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

595

1.32

1.56

2.0

2.1

0.88

0.84

nmol/l

0.19

500

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

199

1.56

1.1

1.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.28

1.55

2.4

3.6

—

22.53

—

(3024932) HLA-DR beta [Type]

107

1.78

1.54

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.03

1.54

1.1

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

332

1.42

1.51

1.2

1.3

—

nmol/l

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

170

1.59

1.48

3.3

2.9

93.74

96.72

0.15

162

(3006922) Hepatitis E virus Ab [Presence] in Serum

210

1.53

1.48

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.12

1.44

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.12

1.44

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.12

1.44

1.3

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.13

1.44

5.2

5.8

360.40

463.38

umol/l

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.31

1.43

10.6

9.6

4.20

6.55

mmol/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.18

1.39

1.3

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

127

1.66

1.36

1.2

—

(3000492) Spirometry study

332

2965

1.13

1.35

1.6

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

240

1.46

1.34

1.2

1.4

—

titre

—

(3006270) Folate [Moles/volume] in Blood

232

1.47

1.34

1.4

1.1

366.96

378.58

nmol/l

0.13

209

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

200

1.50

1.32

1.1

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.36

1.29

1.6

1.2

—

640.53

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.78

1.28

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

226

1.46

1.28

1.1

1.3

3.88

1.19

u/ml

0.72

120

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.00

1.27

1.1

1.2

1.47

200.69

mg/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

587

0.73

1.27

1.8

1.7

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.29

1.26

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

220

1.46

1.23

1.1

—

(40757373) Influenza virus identified in Isolate

1.97

1.22

1.6

1.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.63

1.21

1.0

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.31

1.18

6.2

7.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.85

1.13

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

2.34

1.12

1.1

1.6

—

(40768806) Pleura Pathology biopsy report

251

1.40

1.10

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

168

1.49

1.09

1.2

1.4

5.75

8.10

u/l

0.98

141

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.38

1.09

1.0

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.73

1.08

1.3

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.69

1.07

1.3

1.6

293.93

157.66

nmol/24h

0.40

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.27

1.03

1.2

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.27

1.03

1.0

0.46

4.87

u/ml

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.92

1.02

1.1

—

6.07

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

114

1342

0.84

1.01

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

915

8698

1.07

1.01

4.5

2.38

2.61

ug/l

0.26

833

7859

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.89

1.01

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

664

1.22

1.00

2.1

2.3

66.66

118.99

ug/min

1.29

414

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

663

0.78

1.00

1.5

—

(3014891) Appearance of Pleural fluid

2.00

1.00

1.3

—

(3045142) Bone marrow Pathology biopsy report

308

1.33

1.00

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

125

1068

1.18

1.00

1.8

1.7

—

(3006462) Nitrate [Presence] in Urine

123

1.55

0.99

3.1

3.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

178

1564

1.15

0.99

1.3

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.80

0.96

1.0

1.2

125.50

73.82

ng/l

—

(3000012) Reticulocyte production index

354

1.30

0.96

2.7

2.0

—

(3001556) Androgen free Index in Serum or Plasma

1.89

0.94

1.0

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

3255

32270

1.11

0.92

32.4

19.7

39.83

40.72

3.65

3087

30389

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

175

1.43

0.92

1.4

3.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

175

1.43

0.92

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

2.14

0.91

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.14

0.91

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1155

0.84

0.91

1.7

4.96

4.17

mg/l

0.19

834

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

206

0.63

0.88

2.2

1.6

7.31

7.72

mmol/l

0.43

196

(3009871) Measles virus Ab [Titer] in Serum

103

1.56

0.87

1.4

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

203

1.38

0.87

2.4

2.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

0.87

2.5

2.6

—

(3042517) Benzodiazepines panel - Urine

2.00

0.87

11.5

2.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

478

1.24

0.84

3.5

3.1

0.76

0.85

nmol/l

0.98

365

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.94

0.84

1.7

1.8

76.33

46.94

umol/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

642

1.20

0.84

7.1

4.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

121

1.49

0.82

1.6

1.3

152.69

162.76

mmol/24h

0.15

121

(3039443) Prostate specific Ag panel - Serum or Plasma

611

0.80

0.82

1.7

1.6

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.88

0.81

3.5

2.8

1.25

mg/l

—

(3036603) Volume of Urine

180

1.39

0.81

1.5

1.4

2188.32

1934.12

0.45

175

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

249

1.33

0.81

1.2

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

160

1420

1.13

0.80

1.5

1.4

27.58

26.93

iu/l

0.08

137

1199

(3049717) Cytology report of Urine Cyto stain

112

971

1.16

0.79

2.6

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.79

0.0

1.6

—

0.45

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

448

1.23

0.77

1.2

110.54

43.02

u/l

0.63

385

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

115

1.48

0.76

2.5

4.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.77

0.76

2.5

2.2

—

(3007461) Platelets [#/volume] in Blood

3254

32299

1.09

0.74

32.2

19.6

255.84

252.31

e9/l

2.18

3201

31516

(3030313) Adrenal Ab [Titer] in Serum

2.08

0.74

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.64

0.73

1.2

1.3

—

(3002619) Bacteria identified in Specimen by Culture

1.64

0.73

1.4

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.64

0.73

24.8

7.9

—

(3025577) Chromium [Mass/volume] in Blood

150

1.40

0.73

2.0

2.1

1.70

2.19

ug/l

0.59

130

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

225

2051

1.10

0.73

2.2

2.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.00

0.72

1.0

1.1

18.96

25.38

u/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

202

1.34

0.72

2.3

1.8

—

(3010813) Leukocytes [#/volume] in Blood

3256

32325

1.09

0.72

32.1

19.6

7.04

6.71

e9/l

9.04

3194

31455

(3048879) Bone marrow aspiration report

1.62

0.71

1.9

2.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

182

1643

1.11

0.71

2.2

1.9

—

(3024731) MCV [Entitic volume]

3255

32317

1.09

0.71

32.0

19.5

90.77

90.73

0.17

3219

31894

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.75

0.71

2.3

3.3

—

(3035941) MCH [Entitic mass]

3255

32318

1.09

0.71

31.9

19.5

30.21

30.27

0.90

3218

31892

(3008898) HLA-B27 [Presence]

124

1095

1.14

0.70

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

101

1.49

0.70

7.5

13.8

—

(40768795) Lymph node Pathology biopsy report

256

1.29

0.70

1.3

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.71

0.70

6.0

9.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.55

0.69

1.2

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

3255

32321

1.09

0.69

32.1

19.6

4.45

4.53

e12/l

13.68

3186

31460

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2777

28090

0.95

0.69

4.3

4.2

1.43

1.45

mmol/l

1.93

2575

26180

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.64

0.68

1.1

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.60

0.68

2.3

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

156

0.64

0.67

1.1

1.4

5.54

5.87

mmol/l

—

149

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

688

1.17

0.66

1.3

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

3255

32331

1.09

0.65

32.3

19.7

133.61

136.36

g/l

20.74

3220

31906

(3034274) Bile acid [Moles/volume] in Serum --fasting

351

1.23

0.62

2.6

2.3

8.66

6.83

umol/l

0.45

248

(40761536) Microorganisms panel - Urine sediment

260

2409

1.09

0.62

5.7

3.9

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.1

—

1.55

—

(1617658) Protocol used for examination of sentinel lymph nodes

209

0.72

0.59

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2770

27400

1.05

0.58

4.6

4.3

5.97

5.90

mmol/l

1.79

2548

25183

(3003888) Timothy IgE Ab [Units/volume] in Serum

573

0.84

0.58

1.1

13.01

5.05

u/ml

1.25

303

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

0.26

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.51

0.56

1.7

1.3

31.80

29.91

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.62

0.55

2.5

2.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.62

0.55

2.3

3.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.62

0.55

1.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

266

1.24

0.55

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

459

1.18

0.54

1.6

1.4

0.30

0.35

nmol/l

0.27

361

(3005082) Progesterone [Moles/volume] in Serum or Plasma

126

0.63

0.54

1.1

1.3

24.98

31.29

nmol/l

—

105

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.42

0.54

2.5

2.4

—

(3003338) MCHC [Mass/volume]

2537

25065

1.04

0.53

27.9

16.9

332.42

332.93

g/l

2.01

2517

24868

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.45

0.53

1.7

2.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.43

0.52

24.8

7.6

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.43

0.52

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.50

0.51

1.2

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.39

0.50

2.1

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

529

1.16

0.49

1.5

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2804

28286

0.96

0.49

4.4

4.2

4.64

4.69

mmol/l

1.94

2620

26505

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

353

1.19

0.49

1.1

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

190

1.26

0.47

1.0

1.1

15.02

10.43

iu/ml

—

(3001019) Free T4 and TSH panel - Serum or Plasma

154

1671

0.92

0.47

1.6

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

338

3206

1.06

0.46

1.4

—

(3033799) Differential panel - Peritoneal fluid

0.59

0.45

2.0

2.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2851

28732

0.96

0.44

4.8

4.6

2.74

2.80

mmol/l

2.84

2640

26755

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

490

1.14

0.42

7.0

3.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

152

1407

1.08

0.42

2.7

3.2

36.03

49.29

u/ml

0.86

147

1360

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

794

1.11

0.41

1.2

1.1

2.42

4.75

u/ml

—

106

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

122

1120

1.09

0.41

2.0

1.8

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.41

0.0

1.8

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

391

0.84

0.41

1.1

0.27

0.35

u/ml

0.15

113

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.4

—

15.58

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

172

0.75

0.40

1.8

1.9

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.47

0.40

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.47

0.40

1.0

1.1

—

(3002256) Pathology report gross observation

373

3565

1.05

0.40

1.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

1.18

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

592

0.88

0.39

6.2

3.5

23.16

25.93

mg/l

0.19

373

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.34

0.39

1.0

1.2

99.77

106.89

0.23

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.43

0.39

1.2

1.1

1.61

1.77

umol/24h

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.39

0.0

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

248

0.81

0.39

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

169

1.24

0.38

5.1

6.6

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.36

0.38

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.36

0.38

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.36

0.38

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.36

0.38

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

301

0.83

0.37

1.1

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.35

0.37

1.0

1.4

155.40

112.76

ng/l

—

(3041806) Other cells [#/volume] in Blood by Manual count

115

0.69

0.37

1.0

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.33

0.35

2.1

1.4

9.56

8.77

ug/l

0.22

(3010726) Horse dander IgE Ab [Units/volume] in Serum

533

0.88

0.35

1.1

2.81

1.82

u/ml

0.27

260

(3015076) Soybean IgE Ab [Units/volume] in Serum

172

1.22

0.34

1.0

1.1

0.06

2.05

u/ml

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

218

1.19

0.34

1.8

2.2

2.44

1.98

u/field

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

551

0.89

0.33

1.1

2.15

1.24

u/ml

0.51

235

(3043410) Blood group antigens tested for on Red Blood Cells

0.67

0.33

1.5

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

885

0.91

0.32

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

146

1.23

0.32

1.4

2.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

632

0.90

0.31

1.1

2.83

2.34

u/ml

0.10

318

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

129

1.24

0.30

1.2

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.29

0.30

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

194

1.19

0.29

1.2

1.1

1.20

2.60

u/ml

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

251

1.16

0.28

1.5

27.13

32.92

0.41

159

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

431

1.12

0.28

1.1

2.76

2.99

u/ml

0.07

202

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

149

1.21

0.27

1.9

1.7

1.70

3.77

u/field

—

115

(3003694) ABO and Rh group [Type] in Blood

826

8090

1.03

0.27

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

459

0.89

0.27

1.0

1.1

6.73

3.81

u/ml

0.35

213

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

205

1.17

0.27

16.5

14.5

742.88

846.17

nmol/l

0.41

199

(3038177) Helicobacter pylori Ab [Presence] in Serum

480

1.11

0.27

1.3

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.19

0.26

1.0

1.3

109.13

104.89

—

(3000034) Microalbumin [Mass/volume] in Urine

244

1.15

0.25

2.7

3.1

82.31

41.13

mg/l

0.51

184

(4034850) Laboratory test

100

939

1.07

0.24

8.5

8.8

—

(3020874) Milk IgE Ab [Units/volume] in Serum

190

1.16

0.23

1.1

1.0

3.14

3.12

u/ml

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2699

27130

0.98

0.22

4.0

3.8

1.39

1.31

mmol/l

4.27

2508

25122

(3004775) Volume in Urine collected for unspecified duration

219

1.14

0.22

2.1

2.3

687.94

637.93

0.27

150

(3016750) Collection duration of Urine

172

1.16

0.22

2.1

2.3

517.14

496.26

min

0.36

129

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.19

0.21

3.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.19

0.21

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.21

0.0

1.0

—

173.20

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.04

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

135

1.19

0.21

1.1

1.9

149.63

141.02

0.19

128

(3017569) Oxygen content in Arterial blood

135

1.19

0.21

1.9

2.3

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.42

—

(40765089) Chromosome analysis panel - Blood by G-banded

102

0.78

0.21

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

154

1.17

0.21

1.8

1.4

1.49

1.24

nmol/l

0.40

122

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

173

1.16

0.20

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

187

0.85

0.20

1.3

—

(40768441) Liver Pathology biopsy report

212

1.13

0.19

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

772

1.06

0.19

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

346

1.10

0.19

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

521

5105

1.02

0.19

2.8

2.9

0.67

0.73

ug/l

0.64

341

3234

(3015183) Erythrocyte sedimentation rate

166

1.15

0.18

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.15

0.17

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

709

6984

1.02

0.16

3.8

4.0

20.97

21.52

0.41

307

3185

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

149

1.14

0.15

1.0

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

140

0.86

0.15

1.2

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

189

1.11

0.13

1.6

1.5

22.40

22.72

u/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

335

0.92

0.13

1.1

—

(40768793) Breast Pathology biopsy report

601

0.95

0.12

1.2

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

169

0.89

0.12

1.4

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

102

982

1.04

0.12

1.5

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

143

1390

1.03

0.11

1.2

1.1

286.00

152.45

titre

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

270

0.93

0.10

1.2

1.4

160.23

199.28

pmol/l

0.46

270

(40768800) Prostate Pathology biopsy report

495

0.95

0.10

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.15

0.10

1.0

1.3

83.60

89.30

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.14

0.10

1.0

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.04

0.09

1.0

1.1

12.76

43.21

mg/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

942

1.03

0.08

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.03

0.08

2.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.12

0.07

1.0

1.1

82.60

91.00

—

(3022689) Creatine [Moles/volume] in Urine

0.80

0.07

1.2

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

137

1.10

0.07

1.1

10.21

25.88

u/l

3.50

126

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

194

0.93

0.07

1.2

1.3

1.45

1.56

g/l

1.23

194

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

321

3171

1.01

0.07

1.6

1.7

—

(3020650) Glucose [Presence] in Urine

1.07

0.07

1.4

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

187

1.07

0.06

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

576

0.97

0.05

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

742

7385

1.01

0.04

1.7

1.6

1.50

1.40

mmol/l

0.92

641

6278

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

101

1.09

0.04

1.0

2.0

184.09

154.29

0.53

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

388

1.03

0.04

1.4

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

185

1869

0.99

0.04

1.2

—

(3005033) Fetal Nuchal fold Thickness US

573

0.98

0.03

1.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

421

0.97

0.03

1.0

1.1

3.91

4.87

u/ml

0.28

165

(4146454) Self-monitoring of blood glucose

280

1.04

0.03

3.0

2.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

102

1.08

0.03

2.1

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

108

0.93

0.03

1.1

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

700

1.01

0.02

1.3

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

156

1549

1.01

0.01

1.1

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

701

1.01

0.01

1.3

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

452

4531

1.00

0.01

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

702

1.01

0.01

1.3

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

767

0.99

0.01

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

593

1.01

0.01

1.4

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

703

1.01

0.01

1.3

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

206

0.97

0.00

1.2

1.4

81.80

80.89

umol/l

0.06

206

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

135

1.04

0.00

1.0

1.1

—

(3024263) Appearance of Synovial fluid

135

1.04

0.00

1.6

1.5

—

(1002224) Polysomnography panel

129

1294

1.00

0.00

1.1

—

(44813793) Dust mix specific IgE antibody measurement

185

1.03

0.00

1.1

—

(4281824) Cell count and differential, peritoneal fluid

276

1.01

0.00

1.3

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

229

1.00

0.00

1.3

1.5

0.96

0.97

g/l

0.05

229

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

409

1.00

0.00

2.2

3.0

3.32

73.21

u/ml

1.04

401

(3044007) Cell count panel - Peritoneal fluid

0.92

0.00

1.4

2.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.6

—

2923.32

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1148.13

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.95

-0.00

1.5

1.1

2.50

7.94

u/ml

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.89

-0.00

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

44.00

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

7.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

6.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

0.88

-0.00

3.0

3.1

118.40

99.06

ng/l

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.02

-0.00

1.8

1.1

0.16

0.37

u/ml

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

-0.00

0.0

2.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.8

—

46.40

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

0.88

-0.00

1.0

1.4

—

119.00

titre

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_NEUINFL and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_NEUINFL	2.497 [2.2, 2.84]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.389

During the follow-up period (1.1.1998 — 31.12.2019), 1652 out of 7552 females with G6_NEUINFL died.

Males

Parameter	HR [95% CI]	p-value
G6_NEUINFL	2.74 [2.21, 3.4]	< 0.001
Birth year	0.983 [0.92, 1.05]	0.626

During the follow-up period (1.1.1998 — 31.12.2019), 1966 out of 7915 males with G6_NEUINFL died.

Mortality risk

Mortality risk for people of age

years, who have G6_NEUINFL.

N-year risk	Females	Males
1	0.258%	0.562%
5	1.414%	2.811%
10	3.869%	6.966%
15	7.369%	13.161%
20	13.182%	21.618%

Relationships between endpoints

↥

Index endpoint: G6_NEUINFL – Inflammatory diseases of the central nervous system

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Inflammatory diseases of the central nervous system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints